Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

HSK 1 – For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languagesfree forever.

Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese.

By Bernd Sebastian Kamps and Andrea Melis

  Diabetes

  Free Subscription


Articles published in Diabetologia

Retrieve available abstracts of 510 articles:
HTML format



Single Articles


    June 2026
  1. LAVER TW, Sriram A, Wakeling MN, Siklar Z, et al
    Systematic analysis of loss-of-function variants across MODY genes demonstrates gene-specific effects and expands the spectrum of INS variants causing MODY.
    Diabetologia. 2026;69:1569-1580.
    PubMed     Abstract available


  2. ABDELMOEZ AM, Jollet M, Yu X, Rizo-Roca D, et al
    Thromboxane signalling links immune activation to enhanced glucose uptake in skeletal muscle.
    Diabetologia. 2026;69:1643-1658.
    PubMed     Abstract available


  3. MUSTAFAJEV IF, Hendriksz MS, Stienstra R, Tack CJ, et al
    Adrenaline is a prominent driver of inflammatory responses following hypoglycaemia.
    Diabetologia. 2026;69:1675-1685.
    PubMed     Abstract available


    May 2026
  4. O'REILLY L, Thai LM, Sue N, Dhenni R, et al
    Acute and resolving inflammation differentially regulates beta cell function in mice via interactions between peritoneal and islet-associated macrophages.
    Diabetologia. 2026;69:1249-1264.
    PubMed     Abstract available


  5. CHEN SY, Lekka C, Lemvig J, Yi X, et al
    From pancreas and islet resources to diabetes insights.
    Diabetologia. 2026 May 1. doi: 10.1007/s00125-026-06731.
    PubMed     Abstract available


  6. QUINN LM, Stanley D, Milano F, Perego G, et al
    Psychosocial implications, acceptability and ethics of screening for paediatric type 1 diabetes: a systematic review and mixed methods evidence synthesis.
    Diabetologia. 2026 May 1. doi: 10.1007/s00125-026-06717.
    PubMed     Abstract available


    April 2026
  7. WANG Y, Isasi CR, Stuebe AM, Louis-Jacques AF, et al
    Gestational diabetes and risk of type 2 diabetes: exploring the role of the gut microbiome in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Diabetologia. 2026 Apr 30. doi: 10.1007/s00125-026-06727.
    PubMed     Abstract available


  8. CHEPULIS L, Gan H, Simmons D, Rodrigues M, et al
    SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: insights from a multi-ethnic population.
    Diabetologia. 2026 Apr 27. doi: 10.1007/s00125-026-06733.
    PubMed     Abstract available


  9. MAHAJAN N, Luo Q, Lukkes J, Abhyankar SD, et al
    Bmal1 overexpression in suprachiasmatic nucleus protects from retinal neurovascular deficits in a mouse model of diabetes.
    Diabetologia. 2026 Apr 24. doi: 10.1007/s00125-026-06734.
    PubMed     Abstract available


  10. BABIR FJ, Marcotte-Chenard A, Sandilands RE, D'Amico A, et al
    Exercise snacks performed in real-world settings reduce postprandial hyperglycaemia and glycaemic variability in individuals living with type 2 diabetes: a randomised crossover study.
    Diabetologia. 2026 Apr 24. doi: 10.1007/s00125-026-06741.
    PubMed     Abstract available


  11. MEEKS KAC, van der Linden EL, Bentley AR, Doumatey AP, et al
    Causal relationship between epigenetic markers and type 2 diabetes in West African populations: a Mendelian randomisation analysis.
    Diabetologia. 2026 Apr 24. doi: 10.1007/s00125-026-06716.
    PubMed     Abstract available


  12. SHAMSUTDINOVA D, Stahl D, Das-Munshi J
    Inequalities in type 2 diabetes incidence in a multiethnic population: a cohort study investigating the impact of ethnicity, migration and mental health comorbidities.
    Diabetologia. 2026 Apr 22. doi: 10.1007/s00125-026-06740.
    PubMed     Abstract available


  13. MEHTA K, Morton JI, Chen L, Anstey KJ, et al
    Age- and sex-specific trends in dementia mortality among people with and without diabetes: a multi-country population-based analysis.
    Diabetologia. 2026 Apr 21. doi: 10.1007/s00125-026-06725.
    PubMed     Abstract available


  14. SYED F, Krishnan P, Chang G, Rana J, et al
    Beta cell microRNAs function as molecular hubs of type 1 diabetes pathogenesis and as biomarkers of diabetes risk.
    Diabetologia. 2026 Apr 21. doi: 10.1007/s00125-026-06720.
    PubMed     Abstract available


  15. BLENCOWE M, Saleem Z, Liu R, Wang M, et al
    Multi-tissue multi-omics integration reveals tissue-specific pathways, gene networks and drug candidates for type 1 diabetes.
    Diabetologia. 2026 Apr 15. doi: 10.1007/s00125-026-06721.
    PubMed     Abstract available


  16. BALDWIN FD, Bedair KF, Jorgensen AL, Green L, et al
    Identification of a genetic risk factor for metformin-induced vitamin B(12) deficiency.
    Diabetologia. 2026;69:953-965.
    PubMed     Abstract available


  17. YAJNIK CS, Bandyopadhyay S, Bhat DS, Wagh RSH, et al
    Gestational glycaemia reflects lifelong glycaemia: the Pune Maternal Nutrition Study.
    Diabetologia. 2026;69:930-941.
    PubMed     Abstract available


  18. POWE CE, White F, Allard C, Shook L, et al
    Placental expression of GKN1 and diminished pancreatic beta cell function during pregnancy.
    Diabetologia. 2026;69:1060-1066.
    PubMed     Abstract available


  19. OZDEDE M, Pavlou P, Krasniqi V, Athanasiadou KI, et al
    The impact of blood pressure variability and African Caribbean ethnicity on the progression of diabetic kidney disease in type 1 diabetes.
    Diabetologia. 2026 Apr 1. doi: 10.1007/s00125-026-06715.
    PubMed     Abstract available


    March 2026
  20. SPIES R, Ufer G, Sabia R, Hummel J, et al
    Post-OGTT hypoglycaemia in newly diagnosed type 2 diabetes: frequency, characteristics and cluster assignment.
    Diabetologia. 2026 Mar 27. doi: 10.1007/s00125-026-06719.
    PubMed     Abstract available


  21. KIM JY, Kim S, Kim JH
    Continuous glucose monitoring and risks of acute and chronic diabetes-related complications and mortality in adults with type 1 diabetes: a nationwide cohort study.
    Diabetologia. 2026 Mar 21. doi: 10.1007/s00125-026-06709.
    PubMed     Abstract available


  22. MOLLER PM, Kjobsted R, Petersen MH, de Almeida ME, et al
    Correction: Effect of acute exercise and exercise training on the ability of insulin to clear branched?chain amino acids from plasma in obesity and type 2 diabetes.
    Diabetologia. 2026 Mar 19. doi: 10.1007/s00125-026-06690.
    PubMed    


  23. ZHU D, Ma J, Wang W, Shi B, et al
    Correction: Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial.
    Diabetologia. 2026 Mar 19. doi: 10.1007/s00125-026-06711.
    PubMed    


  24. PENG R, Liu L, Chu X, Xia Z, et al
    Plasma metabolite association profiles for type 2 diabetes genetic clusters in Finnish men.
    Diabetologia. 2026 Mar 18. doi: 10.1007/s00125-026-06710.
    PubMed     Abstract available


  25. DU Y, Zhang M, Li AQY, Lau ESH, et al
    Differential healthcare costs in individuals with type 2 diabetes and incident chronic kidney disease in Hong Kong: a latent class trajectory analysis.
    Diabetologia. 2026 Mar 18. doi: 10.1007/s00125-026-06698.
    PubMed     Abstract available


  26. MCCLURE RD, Carr ALJ, Boule NG, Yardley JE, et al
    The glycaemic response to morning fasted resistance exercise is more consistent than the response to afternoon fed resistance exercise for adults with type 1 diabetes: a randomised crossover comparison.
    Diabetologia. 2026 Mar 14. doi: 10.1007/s00125-026-06713.
    PubMed     Abstract available


  27. BRUTTOMESSO D, Petrie JR, Evans M, Fleming GA, et al
    Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
    Diabetologia. 2026 Mar 12. doi: 10.1007/s00125-025-06651.
    PubMed     Abstract available


  28. CHIRIACO M, Trico D, Giannoni A, Sacchetta L, et al
    Impact of canagliflozin on the cardiorenal effects of dietary sodium intake in type 2 diabetes: a post hoc analysis of the CREDENCE trial.
    Diabetologia. 2026 Mar 12. doi: 10.1007/s00125-026-06705.
    PubMed     Abstract available


  29. CAO J, Liu F, Kong H, Lai C, et al
    Integrated intraocular-plasma proteomics reveals conserved biomarkers for diabetic retinopathy progression: a multi-fluid biopsy study.
    Diabetologia. 2026 Mar 12. doi: 10.1007/s00125-026-06708.
    PubMed     Abstract available


  30. EVANS-MOLINA C, Gitelman SE, Mari A, Ferrannini E, et al
    Beta cell glucose sensitivity identifies clinical response to disease-modifying therapies initiated at stage 3 type 1 diabetes onset.
    Diabetologia. 2026 Mar 12. doi: 10.1007/s00125-026-06703.
    PubMed     Abstract available


  31. CARR ALJ, Sutton H, Agesen RM, Bonifacio E, et al
    Continuous glucose monitoring as a tool in early-stage type 1 diabetes.
    Diabetologia. 2026 Mar 9. doi: 10.1007/s00125-026-06707.
    PubMed     Abstract available


  32. CUNNINGHAM HA, Ward L, Butler MP, Valent AM, et al
    Early meal timing improves nocturnal glucose in pregnancies complicated by gestational diabetes.
    Diabetologia. 2026 Mar 9. doi: 10.1007/s00125-026-06701.
    PubMed     Abstract available


  33. DE ALMEIDA ME, Ortenblad N, Platz AB, Petersen MH, et al
    Mitochondrial cristae density is increased following high-intensity interval training in men with type 2 diabetes.
    Diabetologia. 2026 Mar 8. doi: 10.1007/s00125-026-06694.
    PubMed     Abstract available


  34. HUMBERT A, Nawrot M, Bendridi N, Gouriou Y, et al
    Endoplasmic reticulum-mitochondria contact sites are signalling hubs connecting nutrient sensing and GLP-1 secretion in L cells of the mouse gut: from physiology to obesity and type 2 diabetes.
    Diabetologia. 2026 Mar 8. doi: 10.1007/s00125-026-06693.
    PubMed     Abstract available


  35. JUMENTIER B, Qu HQ, Lu T, Liu K, et al
    Development and validation of a trans-ancestry polygenic risk score for type 1 diabetes.
    Diabetologia. 2026 Mar 7. doi: 10.1007/s00125-026-06706.
    PubMed     Abstract available


  36. PHUAH P, Norton M, Cheng S, Roberts AG, et al
    The microbial tryptophan metabolite indole acts on the gastrointestinal tract to improve glucose homeostasis in a mouse model of diabetes by enhancing GLP-1 secretion and L cell differentiation.
    Diabetologia. 2026 Mar 4. doi: 10.1007/s00125-026-06688.
    PubMed     Abstract available


  37. MA G, Wu W, Duan Y, Yang Y, et al
    A diabetes-induced change of MDM2 SNP309T-->G contributes to aberrant retinal angiogenesis.
    Diabetologia. 2026 Mar 2. doi: 10.1007/s00125-026-06695.
    PubMed     Abstract available


  38. KATTE JC, Bavuma C, Wild SH, Hawkins M, et al
    Atypical diabetes subtypes in Black African populations.
    Diabetologia. 2026 Mar 2. doi: 10.1007/s00125-026-06697.
    PubMed     Abstract available


  39. DANGARDT F, Forsander G, Bergdahl E
    Beyond BMI: the need for improved adiposity assessment in studying subclinical cardiovascular autonomic neuropathy in children with type 1 diabetes. Reply to Risi R, Buzzetti R, Maddaloni E [letter].
    Diabetologia. 2026 Mar 2. doi: 10.1007/s00125-026-06699.
    PubMed    


  40. COUPER JJ, Oakey H, Penno MAS, Wentworth JM, et al
    Evolution of islet autoantibodies in the Environmental Determinants of Islet Autoimmunity (ENDIA) prospective cohort.
    Diabetologia. 2026;69:631-642.
    PubMed     Abstract available


  41. JIANG Y, Wu D, Ni Y, Liu Y, et al
    Peptide hormone spexin restores beta cell function and improves glycaemic control in mice via regulation of the sodium-potassium pump.
    Diabetologia. 2026;69:710-726.
    PubMed     Abstract available


    February 2026
  42. RISI R, Buzzetti R, Maddaloni E
    Beyond BMI: the need for improved adiposity assessment in studying subclinical cardiovascular autonomic neuropathy in children with type 1 diabetes.
    Diabetologia. 2026 Feb 27. doi: 10.1007/s00125-026-06700.
    PubMed    


  43. RUSSON CL, Allen MJ, Cockcroft E, Pemberton JS, et al
    GlucoseGo: a simple tool to predict hypoglycaemia during exercise in type 1 diabetes.
    Diabetologia. 2026 Feb 25. doi: 10.1007/s00125-026-06692.
    PubMed     Abstract available


  44. DOBSON JR, Dadi PK, Dickerson MT, Nakhe AY, et al
    The diabetes-associated K(+) channel TALK-2 controls human beta cell endoplasmic reticulum Ca(2+) handling, which promotes basal insulin release and limits glucose-stimulated insulin secretion.
    Diabetologia. 2026 Feb 25. doi: 10.1007/s00125-026-06683.
    PubMed     Abstract available


  45. YAN H, Liu J, Zhang Z, Chen S, et al
    Canagliflozin attenuates CMR-quantified myocardial fibrosis in individuals with type 2 diabetes mellitus at high cardiovascular risk: a randomised open-label controlled trial.
    Diabetologia. 2026 Feb 24. doi: 10.1007/s00125-026-06682.
    PubMed     Abstract available


  46. FUENTES G, Valero P, Cornejo M, Silva K, et al
    Maternal pre-pregnancy BMI differentially regulates intracellular pH in human umbilical vein endothelium from gestational diabetes mellitus pregnancies, with alkalinisation-associated reduction of adenosine transport in normal weight pregnancies.
    Diabetologia. 2026 Feb 24. doi: 10.1007/s00125-026-06679.
    PubMed     Abstract available


  47. LI Z, Liu S, Ho JC, Narayan KMV, et al
    Subtypes of newly diagnosed type 2 diabetes and risk of complications: analysis of electronic health records in the USA.
    Diabetologia. 2026 Feb 21. doi: 10.1007/s00125-026-06687.
    PubMed     Abstract available


  48. MALTESE G, Karalliedde J, Dhesi J, Bellary S, et al
    Type 1 diabetes, ageing and frailty: an underexplored intersection.
    Diabetologia. 2026 Feb 17. doi: 10.1007/s00125-026-06681.
    PubMed     Abstract available


  49. LUDVIGSSON J
    The rise and fall of a paradigm and conceiving a new hypothesis for type 1 diabetes. Reply to Nerup J, Lernmark A [letter].
    Diabetologia. 2026 Feb 17. doi: 10.1007/s00125-026-06689.
    PubMed    


  50. SEBRAOUI S, Englund O, Nyberg F, Carlsson A, et al
    Geospatial clustering of type 1 diabetes in Sweden: a cohort study based on all residential locations from birth to diagnosis.
    Diabetologia. 2026 Feb 16. doi: 10.1007/s00125-026-06675.
    PubMed     Abstract available


  51. BRUNASSO A, Lange NF, Poli S, Schiavon M, et al
    Novel deuterium metabolic imaging technique reveals distinct patterns of postprandial hepatic glucose homeostasis in individuals with type 1 diabetes and healthy control individuals: a case-control study.
    Diabetologia. 2026 Feb 13. doi: 10.1007/s00125-026-06677.
    PubMed     Abstract available


  52. ZIVKOVIC J, Mitter M, Theodorou D, Moser O, et al
    Exercise in type 1 diabetes: real-world data on glucose levels and hypoglycaemia risk from over 420,000 exercise sessions.
    Diabetologia. 2026 Feb 13. doi: 10.1007/s00125-026-06672.
    PubMed     Abstract available


  53. MARZINOTTO I, Bazzigaluppi E, Brigatti C, Martinenghi S, et al
    Feasibility and performance of minimal-volume capillary blood screening for type 1 diabetes and coeliac disease autoantibodies across all age groups: the UNISCREEN population study.
    Diabetologia. 2026 Feb 10. doi: 10.1007/s00125-026-06680.
    PubMed     Abstract available


  54. KATTNER N, Bashir A, Shaw JAM
    The emerging role of pancreatic exocrine fibrosis as a common aetiological driver of islet dysfunction and diabetes: opportunities for novel disease-modifying interventions.
    Diabetologia. 2026 Feb 10. doi: 10.1007/s00125-026-06678.
    PubMed     Abstract available


  55. BORBJERG MK, Mokhtar S, Sutedja N, Koster A, et al
    Association of corneal nerve parameters with nerve abnormalities and neuropathic pain in prediabetes and type 2 diabetes: the Maastricht Study.
    Diabetologia. 2026 Feb 10. doi: 10.1007/s00125-026-06676.
    PubMed     Abstract available


  56. LAMPOUSI AM, Zeng J, Lofvenborg JE, Carlsson S, et al
    Red meat intake during pregnancy and childhood and risk of type 1 diabetes: findings from the ABIS birth cohort.
    Diabetologia. 2026 Feb 7. doi: 10.1007/s00125-026-06671.
    PubMed     Abstract available


  57. TRINK J, Gao B, Li R, Patel JH, et al
    LASP1 mediates ADAM17 upregulation in high glucose to promote fibrosis in diabetic kidneys.
    Diabetologia. 2026 Feb 6. doi: 10.1007/s00125-025-06662.
    PubMed     Abstract available


  58. SEBASTIAN-VALLES F, Sager-La Ganga C, Justel Enriquez A, Jimenez Blanco S, et al
    Analysis of glycaemic control and treatment satisfaction with a connected smart pen cap in adults with type 1 diabetes: a randomised, open-label, parallel-group trial.
    Diabetologia. 2026 Feb 3. doi: 10.1007/s00125-026-06674.
    PubMed     Abstract available


  59. BLACK SKP, Tully A, Davis EA, Roberts A, et al
    Co-designing a new clinical pathway to support families with children identified as having early-stage type 1 diabetes in Western Australia.
    Diabetologia. 2026 Feb 3. doi: 10.1007/s00125-026-06668.
    PubMed     Abstract available


  60. NAIR AK, Barkho K, Cheranda KP, Traurig M, et al
    Modelling the effects of human SUR1 R1420H variation on insulin secretory function using isogenic iPSC-derived pancreatic islets.
    Diabetologia. 2026;69:399-420.
    PubMed     Abstract available


  61. PREFONTAINE C, Pipella J, Rampazzo Morelli N, Chen YC, et al
    Insulin production is sustained during DNA damage-mediated senescence in adult human beta cells.
    Diabetologia. 2026;69:421-435.
    PubMed     Abstract available


  62. SMEDEGAARD S, Rittig N, Ovesen PG, Suder LB, et al
    Once-daily supplementation with pre-meal whey protein lowers breakfast postprandial glucose levels in women with GDM throughout the third trimester: a randomised, controlled, clinical trial.
    Diabetologia. 2026;69:350-363.
    PubMed     Abstract available


  63. THOMSON RL, Martin G, McGorm KJ, Spelman T, et al
    Perceived stress in mothers of children with and without islet and coeliac autoimmunity in the ENDIA study.
    Diabetologia. 2026;69:343-349.
    PubMed     Abstract available


    January 2026
  64. SIMO R, Hernandez C, Frontoni S, Sbraccia P, et al
    Relationship between retinal neurodysfunction and cognitive impairment in type 2 diabetes: results of the RECOGNISED cross-sectional study.
    Diabetologia. 2026 Jan 29. doi: 10.1007/s00125-025-06664.
    PubMed     Abstract available


  65. GIUDICELLI G, Krause N, Turin-Huet V, Robert M, et al
    Type 2 diabetes remission and metabolic outcomes 5 years after Roux-en-Y gastric bypass in young vs older adults: a multicentre matched cohort study.
    Diabetologia. 2026 Jan 29. doi: 10.1007/s00125-025-06665.
    PubMed     Abstract available


  66. BENTZEN JMM, Brask-Thomsen PK, Krogsbaek M, Hu X, et al
    Dermal fibroblast mitochondrial profiles in painful diabetic neuropathy.
    Diabetologia. 2026 Jan 26. doi: 10.1007/s00125-025-06660.
    PubMed     Abstract available


  67. SHARPE H, Lam GY
    The evolving understanding of cystic fibrosis-related diabetes in the highly effective modulator therapy era: a scoping review.
    Diabetologia. 2026 Jan 26. doi: 10.1007/s00125-025-06653.
    PubMed     Abstract available


  68. GITELMAN SE, Simmons K, Sherr JL, Quattrin T, et al
    Type 1 diabetes screening: reframing the debate from paternalism to partnership. Reply to Scaramuzza AE, Iafusco D, Cherubini V [letter] Type 1 diabetes screening: building a clinician-patient partnership for early care of chronic beta cell failure. R
    Diabetologia. 2026 Jan 24. doi: 10.1007/s00125-026-06673.
    PubMed    


  69. TSAMERET S, Froy O, Matz Y, Landau Z, et al
    Glycaemic, appetite and circadian benefits of a dairy-enriched diet with high-protein breakfast and early daytime-restricted carbohydrate intake in type 2 diabetes: a randomised crossover trial.
    Diabetologia. 2026 Jan 23. doi: 10.1007/s00125-025-06658.
    PubMed     Abstract available


  70. MALLONE R, Bandini A
    Type 1 diabetes screening: building a clinician-patient partnership for early care of chronic beta cell failure.
    Diabetologia. 2026 Jan 23. doi: 10.1007/s00125-025-06656.
    PubMed    


  71. SCARAMUZZA AE, Iafusco D, Cherubini V
    Type 1 diabetes screening: reframing the debate from paternalism to partnership.
    Diabetologia. 2026 Jan 23. doi: 10.1007/s00125-025-06654.
    PubMed    


  72. LEHMANN G, Ehrmann D, Olesen B, Priesterroth LS, et al
    Uncovering distinct predictors of diabetes distress and depressive symptoms in a longitudinal survival analysis of incidence and remission: indication for diverging aetiological paths.
    Diabetologia. 2026 Jan 22. doi: 10.1007/s00125-026-06666.
    PubMed     Abstract available


  73. SYREENI A, Dahlstrom EH, Smyth LJ, Hill C, et al
    Blood DNA methylation markers are associated with diabetic kidney disease progression in type 1 diabetes.
    Diabetologia. 2026 Jan 22. doi: 10.1007/s00125-025-06661.
    PubMed     Abstract available


  74. TOKGOZ S, Deden LN, Hofboer A, Meijer RI, et al
    Beta cell function and mass in individuals with and without remission of type 2 diabetes after Roux-en-Y gastric bypass.
    Diabetologia. 2026 Jan 20. doi: 10.1007/s00125-025-06659.
    PubMed     Abstract available


  75. LAL R, Braune K, Lewis DM, Petruzelkova L, et al
    Fully closed-loop systems: can people with type 1 diabetes just do it? Insights from open-source systems.
    Diabetologia. 2026 Jan 19. doi: 10.1007/s00125-025-06644.
    PubMed     Abstract available


  76. OZ OK, Sherwood AM, Crisologo PA, Killeen AL, et al
    Prospective comparison of WBC SPECT/CT and conventional MRI for diagnosing osteomyelitis and monitoring treatment response in diabetic foot infections.
    Diabetologia. 2026 Jan 18. doi: 10.1007/s00125-025-06652.
    PubMed     Abstract available


  77. KARAKUS KE, Chesshir L, Walker S, Baschal EE, et al
    Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes.
    Diabetologia. 2026 Jan 15. doi: 10.1007/s00125-025-06646.
    PubMed     Abstract available


  78. VERHOOG NJD, Africander D, Storbeck KH
    Sex steroids, SHBG and type 2 diabetes in women: what do we really know?
    Diabetologia. 2026 Jan 15. doi: 10.1007/s00125-025-06647.
    PubMed     Abstract available


  79. WESTHOLM E, Karagiannopoulos A, Nielsen BU, Shaw JAM, et al
    Dynamic changes in circulating microRNAs during oral glucose tolerance testing support their potential as diagnostic and monitoring biomarkers in cystic fibrosis-related diabetes.
    Diabetologia. 2026 Jan 7. doi: 10.1007/s00125-025-06645.
    PubMed     Abstract available


  80. JOING I, Marais G, Huchez A, Lespagnol E, et al
    How adolescents with type 1 diabetes experience physical education in middle school: a qualitative study.
    Diabetologia. 2026 Jan 7. doi: 10.1007/s00125-025-06648.
    PubMed     Abstract available


  81. SINKE L, Delerue T, Wilson R, Lu X, et al
    DNA methylation of genes involved in lipid metabolism drives adiponectin levels and metabolic disease.
    Diabetologia. 2026;69:127-145.
    PubMed     Abstract available


    December 2025
  82. YUN Y, Liu YD, Yang ZM, Wang YQ, et al
    Duodenal myoelectrical hyperactivity drives diabetic remission in rat models of type 2 diabetes.
    Diabetologia. 2025 Dec 26. doi: 10.1007/s00125-025-06642.
    PubMed     Abstract available


  83. BERTUOL VC JR, Iorra F, Vieceli T, Tonolli NT, et al
    Effects of insulin regimens for type 2 diabetes mellitus: a systematic review and network meta-analysis.
    Diabetologia. 2025 Dec 24. doi: 10.1007/s00125-025-06633.
    PubMed     Abstract available


  84. DENROCHE HC, Ng V, Velghe J, Suen I, et al
    Islet amyloid disrupts MHC class II antigen presentation and delays autoimmune diabetes in NOD mice.
    Diabetologia. 2025 Dec 22. doi: 10.1007/s00125-025-06622.
    PubMed     Abstract available


  85. DEWHURST-TRIGG RE, Atkins J, Morgan NG, Eichmann M, et al
    Characterisation of human pancreatic mesenchymal stromal cells in type 1 diabetes.
    Diabetologia. 2025 Dec 21. doi: 10.1007/s00125-025-06634.
    PubMed     Abstract available


  86. CLAUSSEN C, Papadimos E, Magliano DJ, Hotu C, et al
    Prevalence of type 2 diabetes among global Indigenous adult populations: a systematic review.
    Diabetologia. 2025 Dec 21. doi: 10.1007/s00125-025-06624.
    PubMed     Abstract available


  87. NEVES JS, Leite AR, Vale C, Marques P, et al
    Efficacy of tirzepatide versus semaglutide in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial.
    Diabetologia. 2025 Dec 19. doi: 10.1007/s00125-025-06637.
    PubMed     Abstract available


  88. QIN X, Chen S, Sun Y, Ma Z, et al
    Aberrant STING signalling promotes endothelial dysfunction and neurovascular injury in diabetic retinopathy.
    Diabetologia. 2025 Dec 19. doi: 10.1007/s00125-025-06628.
    PubMed     Abstract available


  89. ANJOM-SHOAE J, Fitzgerald PCE, Rose BD, Bitarafan V, et al
    Effects of combined intraduodenal administration of lauric acid and L-tryptophan on postprandial plasma glucose, glucoregulatory hormones and gastric emptying in type 2 diabetes: a double-blind, randomised, crossover study.
    Diabetologia. 2025 Dec 19. doi: 10.1007/s00125-025-06630.
    PubMed     Abstract available


  90. MATTILA M, Haario P, Hakola L, Takkinen HM, et al
    Dietary intake of vitamins A, B, C, D and E and risk of islet autoimmunity and type 1 diabetes in genetically at-risk children: a prospective study from the DIPP birth cohort.
    Diabetologia. 2025 Dec 19. doi: 10.1007/s00125-025-06635.
    PubMed     Abstract available


  91. CHIRIACO M, Trico D, Petrie JR, Gabriel R, et al
    Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: effect sizes and mechanisms.
    Diabetologia. 2025 Dec 18. doi: 10.1007/s00125-025-06643.
    PubMed     Abstract available


  92. ZHOU X, Sevilla-Gonzalez M, Phipps AI, Udler M, et al
    Diabetogenic processes for insulin resistance-linked hyperinsulinaemia are associated with colorectal cancer.
    Diabetologia. 2025 Dec 15. doi: 10.1007/s00125-025-06631.
    PubMed     Abstract available


  93. CHOI W
    Impact of normoglycaemia and prediabetes definitions on the estimated benefits of regression from prediabetes to normoglycaemia for type 2 diabetes risk.
    Diabetologia. 2025 Dec 15. doi: 10.1007/s00125-025-06636.
    PubMed    


  94. JI L, Nai Y, Chen Z, Zhong Y, et al
    alpha7 Nicotinic acetylcholine receptor activation rescues mitochondrial dysfunction in gestational diabetes mellitus by competing with p66Shc for VDAC1 binding.
    Diabetologia. 2025 Dec 15. doi: 10.1007/s00125-025-06640.
    PubMed     Abstract available


  95. KOBAYATI A, Tsoukas MA, Garfield N, Legault L, et al
    Inter- and intra-physician variability in insulin injection adjustments compared with Bayesian algorithm recommendations in type 1 diabetes.
    Diabetologia. 2025 Dec 15. doi: 10.1007/s00125-025-06627.
    PubMed     Abstract available


  96. WANG Y, Ram J, Bianchi C, Fiorentino TV, et al
    Superiority of 1 h plasma glucose vs fasting plasma glucose, 2 h plasma glucose and HbA(1c) for the diagnosis of type 2 diabetes.
    Diabetologia. 2025 Dec 12. doi: 10.1007/s00125-025-06632.
    PubMed     Abstract available


  97. DAVOODIAN N, Lotfaliany M, Huxley RR, Lee CMY, et al
    Impact of normoglycaemia and prediabetes definitions on the estimated benefits of regression from prediabetes to normoglycaemia for type 2 diabetes risk. Reply to Choi W [Letter].
    Diabetologia. 2025 Dec 12. doi: 10.1007/s00125-025-06641.
    PubMed    


  98. LI X, Gong H, Xiong C, Huang X, et al
    LDHA induces beta cell dedifferentiation in diabetes through metabolic and epigenetic reprogramming.
    Diabetologia. 2025 Dec 11. doi: 10.1007/s00125-025-06626.
    PubMed     Abstract available


  99. THIRUMATHYAM R, Richter EA, van Hall G, Andersen NR, et al
    Empagliflozin improves beta cell function independently of relief of glucotoxicity in patients with type 2 diabetes: results from a randomised cross-over study with insulin as comparator.
    Diabetologia. 2025 Dec 9. doi: 10.1007/s00125-025-06616.
    PubMed     Abstract available


  100. MCCARTHY OM, Brodsgaard RB, Tawfik S, Lundemose SB, et al
    Impact of cardiovascular autonomic neuropathy on cardiopulmonary, sympathoadrenal and metabolic responses to physical exercise in adults with type 1 diabetes.
    Diabetologia. 2025 Dec 9. doi: 10.1007/s00125-025-06619.
    PubMed     Abstract available


  101. VEIJOLA R, Tamura RN, Clasen JL, Elding Larsson H, et al
    Family history of type 2 diabetes delays development of type 1 diabetes in TEDDY children with islet autoimmunity.
    Diabetologia. 2025 Dec 8. doi: 10.1007/s00125-025-06613.
    PubMed     Abstract available


  102. DUNCAN MS, Beach LB, Wolfe HL, Restar A, et al
    Sexual orientation, gender identity and cardiometabolic risk: a narrative review.
    Diabetologia. 2025;68:2652-2669.
    PubMed     Abstract available


  103. SCHREMS E, Gruber JR, Schiweck C, Ruf A, et al
    Daily life stress is linked to increased glucose levels in individuals with insulin resistance: a real-world assessment.
    Diabetologia. 2025;68:2709-2718.
    PubMed     Abstract available


  104. LAMARCHE LB, Koch C, Khalid S, Khan MZ, et al
    Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell function.
    Diabetologia. 2025;68:2754-2766.
    PubMed     Abstract available


  105. HO QWC, Miller JA, Gunaseelan D, Chelliah R, et al
    I-BET151 modulates glucokinase gene expression and beta cell function in part through changes in FOXO1 expression.
    Diabetologia. 2025;68:2767-2780.
    PubMed     Abstract available


    November 2025
  106. HIGHTON PJ, Funnell MP, Gupta P, Zaccardi F, et al
    Improving medication adherence in type 2 diabetes: strategies for better clinical and economic outcomes.
    Diabetologia. 2025 Nov 28. doi: 10.1007/s00125-025-06617.
    PubMed     Abstract available


  107. MATSUI S, Yamamoto T, Takabatake Y, Takahashi A, et al
    Defective autophagy and AMPK inactivation drive ferroptosis in diabetic kidney disease.
    Diabetologia. 2025 Nov 28. doi: 10.1007/s00125-025-06612.
    PubMed     Abstract available


  108. BANGSHAAB M, Bengtsen MB, Smedegaard S, Sondergaard E, et al
    Ketone supplementation dose-dependently lowers postprandial blood glucose, lipid and ghrelin levels in individuals with type 2 diabetes: a randomised crossover study.
    Diabetologia. 2025 Nov 28. doi: 10.1007/s00125-025-06614.
    PubMed     Abstract available


  109. CHO SH, Kim S, Oh R, Kim JY, et al
    High incidence of eating disorders in individuals with type 2 diabetes and their association with cardiovascular and mortality risks.
    Diabetologia. 2025 Nov 26. doi: 10.1007/s00125-025-06615.
    PubMed     Abstract available


  110. GUPTA L, Misra A
    From malnutrition-related diabetes mellitus to 'type 5 diabetes': phenotypic variation, not reclassification.
    Diabetologia. 2025 Nov 22. doi: 10.1007/s00125-025-06607.
    PubMed    


  111. BOLDISON J, Leete P, Robinson EJ, Powell W, et al
    CXCR3 expression on antigen-experienced B cells is systemically dysregulated in type 1 diabetes.
    Diabetologia. 2025 Nov 22. doi: 10.1007/s00125-025-06608.
    PubMed     Abstract available


  112. TRIMBLE ER, Phillips DIW, Balcha SA
    From malnutrition-related diabetes mellitus to 'type 5 diabetes': phenotypic variation, not reclassification. Reply to Gupta L, Misra A [letter].
    Diabetologia. 2025 Nov 22. doi: 10.1007/s00125-025-06606.
    PubMed    


  113. MAYNARD AG, Bhardwaj R, Jones TR, Claussnitzer M, et al
    Bridging the variant-to-function gap in type 2 diabetes: advances and challenges.
    Diabetologia. 2025 Nov 22. doi: 10.1007/s00125-025-06600.
    PubMed     Abstract available


  114. ZHU D, Ma J, Wang W, Shi B, et al
    Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial.
    Diabetologia. 2025 Nov 21. doi: 10.1007/s00125-025-06593.
    PubMed     Abstract available


  115. NERUP J, Lernmark A
    The rise and fall of a paradigm and conceiving a new hypothesis for type 1 diabetes.
    Diabetologia. 2025 Nov 21. doi: 10.1007/s00125-025-06610.
    PubMed    


  116. HEIN M, Qambari H, Yu P, Mehnert A, et al
    Interpericyte tunnelling nanotube loss in very early diabetic retinal disease.
    Diabetologia. 2025 Nov 20. doi: 10.1007/s00125-025-06602.
    PubMed     Abstract available


  117. WOUTERS A, Lemaitre P, Degroote L, Viaene M, et al
    Redosing of anti-CD3 antibodies in NOD mice with new-onset diabetes does not alter the effect of a single treatment course.
    Diabetologia. 2025 Nov 20. doi: 10.1007/s00125-025-06604.
    PubMed     Abstract available


  118. BAJRAMAGIC M, Battelino T, Cos X, Cote M, et al
    Artificial intelligence-driven clinical decision support systems to assist healthcare professionals and people with diabetes in Europe at the point of care: a Delphi-based consensus roadmap.
    Diabetologia. 2025 Nov 17. doi: 10.1007/s00125-025-06601.
    PubMed     Abstract available


  119. ZAITOON H, Perl L, Cohen-Sela E, Oren A, et al
    The virtual Morris water maze for cognitive function assessment in adolescents with type 1 diabetes.
    Diabetologia. 2025 Nov 17. doi: 10.1007/s00125-025-06598.
    PubMed     Abstract available


  120. WATANABE-SHIMOJI K, Tanabe H, Ohsugi M, Kawakami E, et al
    Diverse combination of factors associated with the development of diabetic kidney disease among data-driven diabetes subtypes: analysis of the J-DREAMS registry.
    Diabetologia. 2025 Nov 17. doi: 10.1007/s00125-025-06594.
    PubMed     Abstract available


  121. BERGDAHL E, Forsander G, Milkovic L, Sundberg F, et al
    Influence of glycaemic management and BMI on cardiac autonomic markers in children with type 1 diabetes: a prospective cohort study.
    Diabetologia. 2025 Nov 11. doi: 10.1007/s00125-025-06592.
    PubMed     Abstract available


  122. SHAH VN, Xu Y, Dabiri Y, Mohanadas HP, et al
    Association of HbA(1c) and an updated glucose management indicator (uGMI) with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study.
    Diabetologia. 2025 Nov 11. doi: 10.1007/s00125-025-06599.
    PubMed     Abstract available


  123. PATEL SK, Ma CS, Fourlanos S, Greenfield JR, et al
    Clinical, immunogenetic and metabolic characteristics of autoantibody-negative and autoantibody-positive type 1 diabetes.
    Diabetologia. 2025 Nov 11. doi: 10.1007/s00125-025-06580.
    PubMed     Abstract available


  124. FORTEATH C, Merchant HJ, Kocherry C, Murdoch CE, et al
    Recurrent hypoglycaemia promotes cardiomyopathy and cardiac vulnerability in a rodent model of type 1 diabetes.
    Diabetologia. 2025 Nov 10. doi: 10.1007/s00125-025-06574.
    PubMed     Abstract available


  125. JANSZ TT, Young KG, Hopkins R, McGovern AP, et al
    Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection.
    Diabetologia. 2025 Nov 9. doi: 10.1007/s00125-025-06577.
    PubMed     Abstract available


  126. WONG FS, Pearson JA, Wen L
    Is the NOD mouse a good model for type 1 diabetes?
    Diabetologia. 2025 Nov 8. doi: 10.1007/s00125-025-06579.
    PubMed     Abstract available


  127. WU CY, Sharma A, Edwards JD, Liu PP, et al
    Cardiovascular effectiveness and safety of SGLT2 inhibitors vs DPP4 inhibitors by dementia status: a cohort study of older adults with diabetes.
    Diabetologia. 2025 Nov 8. doi: 10.1007/s00125-025-06595.
    PubMed     Abstract available


  128. KUUSELA S, Koskenniemi JJ, Valtanen T, Pokka T, et al
    Islet autoimmunity and progression to type 1 diabetes in the Finnish DIPP study: comparison between genetically susceptible children with and without an affected first-degree relative.
    Diabetologia. 2025 Nov 8. doi: 10.1007/s00125-025-06573.
    PubMed     Abstract available


  129. DIMITROPOULOU NM, Beran M, Eussen SJPM, Dingena CF, et al
    Liver fat content is not elevated in people with type 1 diabetes: the Maastricht Study.
    Diabetologia. 2025 Nov 7. doi: 10.1007/s00125-025-06597.
    PubMed     Abstract available


  130. SCHULTZ ANO, Christensen R, Bollig G, Kidholm K, et al
    Effectiveness of video consultations in type 1 diabetes patients treated with insulin pumps in the outpatient clinic: a randomised controlled trial.
    Diabetologia. 2025 Nov 7. doi: 10.1007/s00125-025-06585.
    PubMed     Abstract available


  131. GITELMAN SE, Simmons K, Sherr JL, Leichter SB, et al
    Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes.
    Diabetologia. 2025 Nov 6. doi: 10.1007/s00125-025-06586.
    PubMed     Abstract available


  132. MISRA S
    Ethnic diversity in precision medicine: a reality or an aspiration?
    Diabetologia. 2025;68:2449-2464.
    PubMed     Abstract available


  133. YUEN L, Hannah W, Hare M, Simmons D, et al
    Hyperglycaemia in pregnancy: the role of ethnicity and geography in risk and outcomes.
    Diabetologia. 2025;68:2340-2361.
    PubMed     Abstract available


  134. ANIAGYEI W, Sarfo-Kantanka O, Mohayideen S, Vivekanandan MM, et al
    Heterogeneity in clinically diagnosed type 1 diabetes: characterising a unique cohort with maintained C-peptide secretion in Ghana.
    Diabetologia. 2025 Nov 1. doi: 10.1007/s00125-025-06576.
    PubMed     Abstract available


    October 2025
  135. BAILEY CJ
    Pharmacological therapies for type 2 diabetes: future approaches.
    Diabetologia. 2025 Oct 31. doi: 10.1007/s00125-025-06581.
    PubMed     Abstract available


  136. STIMSON RH, Dover AR, Clarke C, Conceicao C, et al
    Persistent C-peptide secretion is associated with favourable CGM metrics in adults with type 1 diabetes.
    Diabetologia. 2025 Oct 30. doi: 10.1007/s00125-025-06578.
    PubMed     Abstract available


  137. LIU W, Deng B
    Diabetes heterogeneity beyond 3.8 years: missed risks of silent hypoglycaemia and long-term complications in the 4C study.
    Diabetologia. 2025 Oct 30. doi: 10.1007/s00125-025-06588.
    PubMed    


  138. WANG S, Jia X, Yin Y, Lin H, et al
    Diabetes heterogeneity beyond 3.8 years: missed risks of silent hypoglycaemia and long-term complications in the 4C study. Reply to Liu W, Deng B [letter].
    Diabetologia. 2025 Oct 29. doi: 10.1007/s00125-025-06589.
    PubMed    


  139. TOKORO MF, Mita T, Osonoi Y, Someya Y, et al
    An evening chronotype is associated with the incidence and progression of diabetic retinopathy in people with type 2 diabetes mellitus: a cohort study.
    Diabetologia. 2025 Oct 24. doi: 10.1007/s00125-025-06590.
    PubMed     Abstract available


  140. COLOMBIJN JMT, de Leijer JF, Visseren FLJ, Verhaar MC, et al
    Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies.
    Diabetologia. 2025 Oct 21. doi: 10.1007/s00125-025-06565.
    PubMed     Abstract available


  141. ZHA D, Gamez J, Ebrahimi SM, Wang Y, et al
    Oxidative stress-regulatory role of miR-10b-5p in the diabetic human cornea revealed through integrated multi-omics analysis.
    Diabetologia. 2025 Oct 20. doi: 10.1007/s00125-025-06558.
    PubMed     Abstract available


  142. DAVOODIAN N, Lotfaliany M, Huxley RR, Lee CMY, et al
    Regression from prediabetes to normoglycaemia and the role of cardiometabolic risk factors on the subsequent risk of developing type 2 diabetes.
    Diabetologia. 2025 Oct 18. doi: 10.1007/s00125-025-06555.
    PubMed     Abstract available


  143. VERCALSTEREN E, Karampatsi D, Neicu M, Romanitan MO, et al
    Pre-stroke weight loss by glucagon-like peptide 1 receptor and neuropeptide Y receptor Y2 activation improves post-stroke functional recovery in male diabetic mouse models.
    Diabetologia. 2025 Oct 15. doi: 10.1007/s00125-025-06567.
    PubMed     Abstract available


  144. ZHU R, Guo J, Huttunen-Lenz M, Silvestre M, et al
    Long-term effects of dietary protein and carbohydrate quality on prediabetes remission: results from the PREVIEW randomised multinational diabetes prevention trial.
    Diabetologia. 2025 Oct 15. doi: 10.1007/s00125-025-06560.
    PubMed     Abstract available


  145. FAGHER K, Eeg-Olofsson K, Arnqvist H, Bolinder J, et al
    Uric acid and future complications in young individuals with type 1 diabetes: results from the Diabetes Incidence Study in Sweden (DISS) and the National Diabetes Registry of Sweden (NDR).
    Diabetologia. 2025 Oct 14. doi: 10.1007/s00125-025-06561.
    PubMed     Abstract available


  146. PERNG W, Shu S, Nathan DM, Luchsinger JA, et al
    Shared and distinct metabolomics profiles associated with microvascular complications in the Diabetes Prevention Program Outcomes Study.
    Diabetologia. 2025 Oct 11. doi: 10.1007/s00125-025-06571.
    PubMed     Abstract available


  147. MA C, Zeng H
    Methodological considerations for interpreting long-term statin use and diabetes incidence.
    Diabetologia. 2025 Oct 9. doi: 10.1007/s00125-025-06568.
    PubMed    


  148. O'CONNELL MA, Beare R, Messazos B, Northam EA, et al
    Acute brain responses to hypoglycaemia and hyperglycaemia in adolescents with type 1 diabetes.
    Diabetologia. 2025 Oct 7. doi: 10.1007/s00125-025-06548.
    PubMed     Abstract available


  149. SLOAN G, Teh K, Greig M, Shillo P, et al
    Beyond pain relief: the effects of chronic opioid use on brain structure and function in diabetic neuropathy-a multimodal neuroimaging study.
    Diabetologia. 2025 Oct 6. doi: 10.1007/s00125-025-06529.
    PubMed     Abstract available


  150. BUCKLEY AJ, Tan GD, Gruszka-Goh M, Scanlon PH, et al
    No evidence that tirzepatide can worsen diabetic retinopathy. Reply to Fadini GP [letter]. Reassessing retinopathy risk with tirzepatide therapy. Reply to Zhang N, Wang W, Wan G [letter].
    Diabetologia. 2025 Oct 6. doi: 10.1007/s00125-025-06562.
    PubMed    


  151. FADINI GP
    No evidence that tirzepatide can worsen diabetic retinopathy.
    Diabetologia. 2025 Oct 6. doi: 10.1007/s00125-025-06564.
    PubMed    


  152. ZHANG Y, Giovannucci EL, Wang DD
    Methodological considerations for interpreting long-term statin use and diabetes incidence. Reply to Ma C, Zeng H [letter].
    Diabetologia. 2025 Oct 3. doi: 10.1007/s00125-025-06569.
    PubMed    


  153. MICHALEK DA, Tern C, Robertson CC, Chen WM, et al
    HLA-focused type 1 diabetes genetic risk prediction in populations of diverse ancestry.
    Diabetologia. 2025 Oct 2. doi: 10.1007/s00125-025-06563.
    PubMed     Abstract available


  154. PAPADIMOS ER, Claussen C, Magliano DJ, Hotu C, et al
    Prevalence of youth type 2 diabetes in global Indigenous populations: a systematic review.
    Diabetologia. 2025 Oct 2. doi: 10.1007/s00125-025-06556.
    PubMed     Abstract available


  155. ALBARGOTHY MJ, Troendle EP, Laws R, Barabas P, et al
    3D electron microscopy reveals novel ultrastructural changes in the diabetic retinal neurovascular unit.
    Diabetologia. 2025 Oct 2. doi: 10.1007/s00125-025-06554.
    PubMed     Abstract available


  156. WHELEHAN G, Hakim O, Ladwa M, Bello O, et al
    Ethnic differences in beta cell function and pancreatic fat in Black African and White European men across a spectrum of glucose tolerance.
    Diabetologia. 2025;68:2290-2295.
    PubMed     Abstract available


  157. ANDERSEN AK, Lyng KD, Faerch K, Vistisen D, et al
    What are the most important research questions within prediabetes? A priority setting partnership in collaboration with patients, healthcare professionals and researchers.
    Diabetologia. 2025;68:2156-2167.
    PubMed     Abstract available


  158. ZHANG RX, Li AQ, Zhao XY, Wang B, et al
    Identification of SEC16B as a novel regulator of glucose homeostasis.
    Diabetologia. 2025;68:2247-2262.
    PubMed     Abstract available


  159. MARUCCI A, Derhourhi M, Menzaghi C, Fini G, et al
    The role of SLC19A2 variants in the wide spectrum of non-autoimmune abnormalities of glucose homeostasis.
    Diabetologia. 2025;68:2240-2246.
    PubMed     Abstract available


  160. DENG Y, Wu H, Ng NYH, Tam CHT, et al
    Association between maternal glucose levels in pregnancy and offspring's metabolism and adiposity: an 18-year birth cohort study.
    Diabetologia. 2025;68:2205-2216.
    PubMed     Abstract available


    September 2025
  161. TRIMBLE ER, Phillips DIW, Balcha SA
    Phenotype of insulin-dependent diabetes in chronic undernutrition: beta cell stress and immune dysfunction-a rural sub-Saharan perspective on type 5 diabetes.
    Diabetologia. 2025 Sep 29. doi: 10.1007/s00125-025-06553.
    PubMed     Abstract available


  162. ZHAO LP, Papadopoulos GK, McFarland BJ, Skyler JS, et al
    Correction: Profiling associations of interactive ligand-receptors (HLA class I and KIR gene products) with the progression to type 1 diabetes among seroconverted participants.
    Diabetologia. 2025 Sep 27. doi: 10.1007/s00125-025-06557.
    PubMed    


  163. CASTELBLANCO E, Shyr ZA, Ramirez-Sotero I, Yan Z, et al
    Restoration of pancreatic beta cell identity and autophagy in K(ATP)-induced diabetes by intermittent fasting.
    Diabetologia. 2025 Sep 25. doi: 10.1007/s00125-025-06545.
    PubMed     Abstract available


  164. DYSON NJ, Kattner N, Al-Selwi Y, Honkanen-Scott M, et al
    Quantitative analysis of human adult pancreatic histology reveals separate fatty and fibrotic phenotypes in type 2 diabetes.
    Diabetologia. 2025 Sep 24. doi: 10.1007/s00125-025-06547.
    PubMed     Abstract available


  165. TOLEDO FGS, Li Y, Wang F, Bellin MD, et al
    Pancreatic cancer-related diabetes and type 2 diabetes differ in multiple aspects of glucose homeostasis.
    Diabetologia. 2025 Sep 24. doi: 10.1007/s00125-025-06543.
    PubMed     Abstract available


  166. KVIST AAS, Sharma A, Qvigstad E, Sattar N, et al
    Differences in tissue-specific insulin resistance between South Asian and Nordic women with prediabetes after gestational diabetes.
    Diabetologia. 2025 Sep 24. doi: 10.1007/s00125-025-06546.
    PubMed     Abstract available


  167. HOYER KL, Kornum DS, Baunwall SMD, Klinge MW, et al
    Repeated faecal microbiota transplantation for individuals with type 1 diabetes and gastroenteropathy.
    Diabetologia. 2025 Sep 18. doi: 10.1007/s00125-025-06544.
    PubMed     Abstract available


  168. DIETLER D, Bjork J, Palmkvist E, Carlsson A, et al
    Trends in type 1 diabetes incidence between 2007 and 2023 and their association with SARS-CoV-2 infection in a population-based matched cohort study among individuals under 30 years old in Sweden.
    Diabetologia. 2025 Sep 18. doi: 10.1007/s00125-025-06540.
    PubMed     Abstract available


  169. GIORGINO F, Alzaid F, Pantea Stoian A, Chan JCN, et al
    Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council.
    Diabetologia. 2025 Sep 10. doi: 10.1007/s00125-025-06504.
    PubMed     Abstract available


  170. CANHA D, Choudhary P, Cosson E, Banu I, et al
    Time below range alone is insufficient to identify severe hypoglycaemia risk in type 1 diabetes-the critical role of hypoglycaemia awareness: results from the SFDT1 study.
    Diabetologia. 2025 Sep 9. doi: 10.1007/s00125-025-06536.
    PubMed     Abstract available


  171. SUBRAMANIAN V, Sherman AS, Holst JJ, Knop FK, et al
    Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations.
    Diabetologia. 2025 Sep 9. doi: 10.1007/s00125-025-06524.
    PubMed     Abstract available


  172. CIVIT-URGELL A, Pena E, Bejar MT, Moscatiello F, et al
    bFGF rescues dysfunctional properties of adipose-derived stem cells from individuals with type 2 diabetes by modulating their miRNA profile.
    Diabetologia. 2025 Sep 4. doi: 10.1007/s00125-025-06533.
    PubMed     Abstract available


  173. GU X, Wei Y
    The relationship between shrunken pore syndrome/selective glomerular hypofiltration syndromes and all-cause mortality in the Fremantle Diabetes Study Phase II.
    Diabetologia. 2025 Sep 4. doi: 10.1007/s00125-025-06531.
    PubMed    


  174. BRUCE DG, Davis WA, Chubb SAP, Davis TME, et al
    The relationship between shrunken pore syndrome/selective glomerular hypofiltration syndromes and all-cause mortality in the Fremantle Diabetes Study Phase II. Reply to Gu X, Wei Y [letter].
    Diabetologia. 2025 Sep 4. doi: 10.1007/s00125-025-06532.
    PubMed    


  175. PETKOVIC M, Leal EC, Sorensen AE, Jorgensen PT, et al
    Improved wound healing by dual inhibition of miR-146a-5p and miR-29a-3p supports a network action of dysregulated miRNAs in diabetic skin.
    Diabetologia. 2025 Sep 3. doi: 10.1007/s00125-025-06522.
    PubMed     Abstract available


  176. MUNGKALASUT P, Chanda M, Jugnam-Ang W, Cheepsunthorn P, et al
    Glucose 6-phosphate dehydrogenase deficiency and Southeast Asian-specific mutations lower HbA(1c) levels in a Thai population: implications for diabetes diagnosis.
    Diabetologia. 2025 Sep 1. doi: 10.1007/s00125-025-06523.
    PubMed     Abstract available


  177. GOMEZ-MEDINA AM, Henao-Carillo DC, Villamil-Castaneda LP, Gomez-Quesada Y, et al
    Insulin DEgludec/LIraglutide versus multiple daily insulin injections in the transition from hospital to outpatient management assessed by continuous glucose monitoring: the DELI transition trial.
    Diabetologia. 2025;68:1899-1907.
    PubMed     Abstract available


  178. BRISNOVALI NF, Franco I, Abdelgawwad A, Tsou HLP, et al
    Effects of SGLT2 ablation or inhibition on corticosterone secretion in high-fat-fed mice: exploring a nexus with cytokine levels.
    Diabetologia. 2025;68:2042-2056.
    PubMed     Abstract available


  179. DIMITROPOULOU NM, Eussen SJPM, Schalkwijk CG, de Galan BE, et al
    Glucose variability measured by continuous glucose monitoring is associated with skin autofluorescence: the Maastricht Study.
    Diabetologia. 2025;68:1937-1946.
    PubMed     Abstract available


    August 2025
  180. JIA X, Wang S, Lin H, Zhu Y, et al
    Heterogeneity of diabetes and disease progression with a tree-like representation: findings from the China Cardiometabolic Disease and Cancer Cohort (4C) study.
    Diabetologia. 2025 Aug 30. doi: 10.1007/s00125-025-06528.
    PubMed     Abstract available



  181. 61(st) EASD Annual Meeting of the European Association for the Study of Diabetes : Vienna, Austria, 15 - 19 September 2025.
    Diabetologia. 2025 Aug 26. doi: 10.1007/s00125-025-06497.
    PubMed    


  182. ZHAO LP, Papadopoulos GK, McFarland BJ, Skyler JS, et al
    Profiling associations of interactive ligand-receptors (HLA class I and KIR gene products) with the progression to type 1 diabetes among seroconverted participants.
    Diabetologia. 2025 Aug 21. doi: 10.1007/s00125-025-06520.
    PubMed     Abstract available


  183. YU MG, Shah H, Jangolla S, Gauthier J, et al
    Risk and protective factors for coronary atherosclerosis and myocardial dysfunction in individuals with long-duration type 1 diabetes.
    Diabetologia. 2025 Aug 20. doi: 10.1007/s00125-025-06521.
    PubMed     Abstract available


  184. SHI C, Wang X, Qin S, He A, et al
    BCKDK accelerates the progression of diabetic kidney disease by regulating leucine-mediated metabolic remodelling in renal tubular cells.
    Diabetologia. 2025 Aug 16. doi: 10.1007/s00125-025-06519.
    PubMed     Abstract available


  185. HUHN EA, Kotzaeridi G, Fischer T, Todesco Bernasconi M, et al
    The utility of early gestational OGTT and biomarkers for the development of gestational diabetes mellitus: an international prospective multicentre cohort study.
    Diabetologia. 2025 Aug 16. doi: 10.1007/s00125-025-06517.
    PubMed     Abstract available


  186. SPEKSNIJDER EM, Simsek S, Bisschop PH, Stenvers DJ, et al
    Perceived blood glucose regulation after menopause: a cross-sectional survey in women with type 1 diabetes in the Netherlands.
    Diabetologia. 2025 Aug 16. doi: 10.1007/s00125-025-06518.
    PubMed     Abstract available


  187. AUGUSTINE J, Troendle EP, Friedel T, Baldwin C, et al
    Scavenging acrolein with 2-HDP preserves neurovascular integrity in a rat model of diabetic retinal disease.
    Diabetologia. 2025 Aug 15. doi: 10.1007/s00125-025-06515.
    PubMed     Abstract available


  188. HERDER C, Pritlove C, Chaturvedi N, Mulder H, et al
    Diabetes prevention and treatment: a global perspective.
    Diabetologia. 2025 Aug 12. doi: 10.1007/s00125-025-06511.
    PubMed    


  189. MYTKOLLI L, Ahmed A, Ajmal S, Alvarez Pagola A, et al
    Diabetes in four dialects: a global call for equity across lived, loved, learned and laboured experiences.
    Diabetologia. 2025 Aug 9. doi: 10.1007/s00125-025-06506.
    PubMed    


  190. KENNEDY B, Wernroth ML, Langenskiold S, Bonander C, et al
    The impact of child type 1 diabetes on parental incomes in a welfare state context: quasi-experimental evidence from Swedish national registers.
    Diabetologia. 2025 Aug 8. doi: 10.1007/s00125-025-06492.
    PubMed     Abstract available


  191. ROTH-SCHULZE AJ, Bandala-Sanchez E, Ngui KM, Naselli G, et al
    Adverse pregnancy outcomes in women with type 1 diabetes are associated with multiple alterations in the vaginal microbiome.
    Diabetologia. 2025 Aug 7. doi: 10.1007/s00125-025-06509.
    PubMed     Abstract available


  192. CHATURVEDI N, Voight BF, Wells JC, Pritlove C, et al
    Race, ethnicity and ancestry in global diabetes research: grappling with complexity to advance equity and scientific integrity - a narrative review and viewpoint.
    Diabetologia. 2025 Aug 7. doi: 10.1007/s00125-025-06516.
    PubMed     Abstract available


  193. STENE LC
    Perspectives on prevention of type 1 diabetes and heterogeneities.
    Diabetologia. 2025 Aug 6. doi: 10.1007/s00125-025-06512.
    PubMed     Abstract available


  194. YAU B, Ghislain J, Kebede MA, Hughes J, et al
    The role of the beta cell in type 2 diabetes: new findings from the last 5 years.
    Diabetologia. 2025 Aug 6. doi: 10.1007/s00125-025-06499.
    PubMed     Abstract available


  195. PARAJULI A, Bendes A, Byvald F, Stone VM, et al
    Frequent longitudinal blood microsampling and proteome monitoring identify disease markers and enable timely intervention in a mouse model of type 1 diabetes.
    Diabetologia. 2025 Aug 4. doi: 10.1007/s00125-025-06502.
    PubMed     Abstract available


  196. GONG JY, Sajjadi SF, Motala AA, Shaw JE, et al
    Variation in type 2 diabetes prevalence across different populations: the key drivers.
    Diabetologia. 2025 Aug 4. doi: 10.1007/s00125-025-06478.
    PubMed     Abstract available


  197. WRIGHT AK, Huang T, Carr MJ, Premdayal AD, et al
    Clinical utility of self-reported sleep duration and insomnia symptoms in type 2 diabetes prediction.
    Diabetologia. 2025 Aug 2. doi: 10.1007/s00125-025-06503.
    PubMed     Abstract available


  198. KIM S, Park SH, Lee JA, Cho SH, et al
    Time in tight range and time in range for predicting the achievement of typical glucose management indicator and HbA(1c) targets.
    Diabetologia. 2025;68:1674-1679.
    PubMed     Abstract available


  199. DUTTA A, Dutta PK, Baruah SM, Dihingia P, et al
    Non-autoimmune diabetes in young people from Assam, India: the PHENOEINDY-2 study.
    Diabetologia. 2025 Aug 1. doi: 10.1007/s00125-025-06500.
    PubMed     Abstract available


    July 2025
  200. MUNOZ-PARDEZA J, Lopez-Gil JF, Hormazabal-Aguayo I, Huerta-Uribe N, et al
    Compositional analysis of the association between 24 h movement behaviours, HbA(1c) and interstitial glucose in children and adolescents with type 1 diabetes mellitus: a two-year longitudinal analysis of the Diactive-1 cohort study.
    Diabetologia. 2025 Jul 31. doi: 10.1007/s00125-025-06496.
    PubMed     Abstract available


  201. KALHAN TA, Luo M, Chai JH, Tai ES, et al
    Health economic evaluation of a risk-stratified intervention in diabetic kidney disease.
    Diabetologia. 2025 Jul 30. doi: 10.1007/s00125-025-06498.
    PubMed     Abstract available


  202. EVANS-MOLINA C, Dor Y, Lernmark A, Mathieu C, et al
    The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetologia. 2025 Jul 30. doi: 10.1007/s00125-025-06462.
    PubMed     Abstract available


  203. HWANG JJ, Bini J, Belfort-DeAguiar R
    Measurement of brain glucose metabolism in obesity and diabetes.
    Diabetologia. 2025 Jul 25. doi: 10.1007/s00125-025-06491.
    PubMed     Abstract available


  204. MORI T, Zaharia OP, Strassburger K, Dennis JM, et al
    Recognising, quantifying and accounting for classification uncertainty in type 2 diabetes subtypes.
    Diabetologia. 2025 Jul 25. doi: 10.1007/s00125-025-06486.
    PubMed     Abstract available


  205. LUK AOY, Fan Y, Fan B, Chow EWK, et al
    Heterogeneity in the development of diabetes-related complications: narrative review of the roles of ancestry and geographical determinants.
    Diabetologia. 2025 Jul 22. doi: 10.1007/s00125-025-06482.
    PubMed     Abstract available


  206. ADDALA A, Amedari MI, Figg LE, Ebekozien O, et al
    Disparities in access to and use of diabetes technologies and therapeutics: a narrative review.
    Diabetologia. 2025 Jul 22. doi: 10.1007/s00125-025-06494.
    PubMed     Abstract available


  207. YAMAGUCHI Y, Kuwata H, Imura M, Moyama S, et al
    Early induction of insulin sensitisation treated by tirzepatide: a prospective, single-arm, open-label study in Japanese individuals with obesity and type 2 diabetes.
    Diabetologia. 2025 Jul 22. doi: 10.1007/s00125-025-06493.
    PubMed     Abstract available


  208. RUSS-SILSBY J, Teles M, Hassan SS, Elbarbary NS, et al
    Global perspectives on monogenic forms of diabetes.
    Diabetologia. 2025 Jul 16. doi: 10.1007/s00125-025-06495.
    PubMed     Abstract available


  209. NIELSEN H, Lajeunesse-Trempe F, Lin AL, Nielsen MH, et al
    Societal and biological approaches to diabetes prevention and care for Inuit populations: a narrative review.
    Diabetologia. 2025 Jul 15. doi: 10.1007/s00125-025-06487.
    PubMed     Abstract available


  210. DEGROOTE L, Martens PJ, Viaene M, Heremans Y, et al
    Verapamil and low-dose anti-mouse thymocyte globulin combination therapy stably reverses recent-onset type 1 diabetes in NOD mice by acting on the beta cell and immune axes.
    Diabetologia. 2025 Jul 12. doi: 10.1007/s00125-025-06490.
    PubMed     Abstract available


  211. BUCKLEY AJ, Tan GD, Gruszka-Goh M, Scanlon PH, et al
    Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study.
    Diabetologia. 2025 Jul 10. doi: 10.1007/s00125-025-06466.
    PubMed     Abstract available


  212. GUBELI A, Steiner N, Limacher A, Mathis D, et al
    Dapagliflozin's impact on hormonal regulation and ketogenesis in type 1 diabetes: a randomised controlled crossover trial.
    Diabetologia. 2025 Jul 9. doi: 10.1007/s00125-025-06481.
    PubMed     Abstract available


  213. HERDER C, Zhu A, Schmitt A, Spagnuolo MC, et al
    Biomarkers of inflammation and improvement in depressive symptoms in type 1 and type 2 diabetes: differential associations with depressive symptom clusters.
    Diabetologia. 2025 Jul 8. doi: 10.1007/s00125-025-06472.
    PubMed     Abstract available


  214. XU QH, Huang YJ
    Rethinking the link between gestational diabetes and dementia risk.
    Diabetologia. 2025 Jul 2. doi: 10.1007/s00125-025-06480.
    PubMed    


  215. HENRIKSEN K, Rufer C, Title AC, Jawurek S, et al
    Proinflammatory cytokine-induced alpha cell impairment in human islet microtissues is partially restored by dual incretin receptor agonism.
    Diabetologia. 2025;68:1492-1508.
    PubMed     Abstract available


  216. MOEN GH, Hwang LD, Brito Nunes C, Warrington NM, et al
    The genetics of low and high birthweight and their relationship with cardiometabolic disease.
    Diabetologia. 2025;68:1452-1462.
    PubMed     Abstract available


  217. EHRMANN D, Krause-Steinrauf H, Uschner D, Wen H, et al
    Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance: cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study.
    Diabetologia. 2025;68:1403-1415.
    PubMed     Abstract available


  218. CORBIN LJ, Merino J, Fall T, Herder C, et al
    Raising the bar for publication of Mendelian randomisation studies in Diabetologia.
    Diabetologia. 2025 Jul 1. doi: 10.1007/s00125-025-06484.
    PubMed    


    June 2025
  219. KELLER MJ, Brady AJ, Smith JAB, Savikj M, et al
    Inflammatory markers and blood glucose are higher after morning vs afternoon exercise in type 2 diabetes.
    Diabetologia. 2025 Jun 28. doi: 10.1007/s00125-025-06477.
    PubMed     Abstract available


  220. MICHEL M, Flahault A, Coliche V, Alla A, et al
    Differences in biopsy-proven diabetic kidney disease in individuals from Polynesia vs mainland France: a retrospective cohort study.
    Diabetologia. 2025 Jun 27. doi: 10.1007/s00125-025-06471.
    PubMed     Abstract available


  221. PATEL K, Eastwood SV, Wells JC, Chaturvedi N, et al
    Diabetogenic elevated childhood total fat in South Asian and Black African/Caribbean people relates to adverse early life growth and low socioeconomic position compared with White people in the UK.
    Diabetologia. 2025 Jun 27. doi: 10.1007/s00125-025-06473.
    PubMed     Abstract available


  222. HU J, Jiang G, Qin J, Luo S, et al
    A type 1 diabetes genetic risk score discriminates between type 1 diabetes and type 2 diabetes in a Chinese population.
    Diabetologia. 2025 Jun 26. doi: 10.1007/s00125-025-06455.
    PubMed     Abstract available


  223. ABRAMOFF KJ, Maloney SK, Jones TW, Davis EA, et al
    Does exercise in cool water cause a higher risk of hypoglycaemia than in thermoneutral conditions in type 1 diabetes?
    Diabetologia. 2025 Jun 18. doi: 10.1007/s00125-025-06456.
    PubMed     Abstract available


  224. LEHNER CT, Eberl M, Donnachie E, Tanaka LF, et al
    Correction: Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people.
    Diabetologia. 2025 Jun 17. doi: 10.1007/s00125-025-06460.
    PubMed    


  225. DENG Y, Tam CHT, Yang A, Shi M, et al
    Association of maternal overweight and gestational diabetes mellitus with offspring adiposity trajectory: from birth to early adolescence.
    Diabetologia. 2025 Jun 17. doi: 10.1007/s00125-025-06468.
    PubMed     Abstract available


  226. ZHOU Y, Hu L, Zhuang R, Song L, et al
    METRNL represses beta-to-alpha cell trans-differentiation to maintain beta cell function under diabetic metabolic stress in mice.
    Diabetologia. 2025 Jun 10. doi: 10.1007/s00125-025-06459.
    PubMed     Abstract available


  227. GUYER P, Seminova K, Lugar M, Manganaro A, et al
    T cell and autoantibody recognition of nucleus-associated islet autoantigens in individuals with type 1 diabetes.
    Diabetologia. 2025 Jun 9. doi: 10.1007/s00125-025-06458.
    PubMed     Abstract available


  228. BENNET L, Agyemang C
    Prevention of type 2 diabetes in migrant populations from low- and middle-income countries living in high-income countries.
    Diabetologia. 2025 Jun 7. doi: 10.1007/s00125-025-06465.
    PubMed     Abstract available


  229. COSTABILE G, Salamone D, Della Pepa G, Testa R, et al
    ApoC-III and ectopic fat accumulation in individuals with type 2 diabetes: an exploratory analysis from the MEDEA randomised controlled study.
    Diabetologia. 2025 Jun 5. doi: 10.1007/s00125-025-06464.
    PubMed     Abstract available


  230. DEKKER E, de Winter TJJ, Munoz Garcia A, de Graaf N, et al
    BMP5 signalling in beta cells and the impact on insulin secretion in the context of type 2 diabetes.
    Diabetologia. 2025 Jun 5. doi: 10.1007/s00125-025-06457.
    PubMed     Abstract available


  231. KUO CC, Chuang MH, Li CH, Tsai YW, et al
    Glucagon-like peptide-1 receptor agonists and gastrointestinal cancer risk in individuals with type 2 diabetes.
    Diabetologia. 2025 Jun 5. doi: 10.1007/s00125-025-06453.
    PubMed     Abstract available


  232. ALZAID F, Fagherazzi G, Riveline JP, Bahman F, et al
    Immune cell-adipose tissue crosstalk in metabolic diseases with a focus on type 1 diabetes.
    Diabetologia. 2025 Jun 4. doi: 10.1007/s00125-025-06437.
    PubMed     Abstract available


  233. EL TOBGY NA, Grewal EK, Gonzalez PM, Tibebu T, et al
    Interventions to improve diabetes care and self-management for individuals experiencing homelessness: a scoping review with systematic search of qualitative and quantitative literature.
    Diabetologia. 2025 Jun 3. doi: 10.1007/s00125-025-06449.
    PubMed     Abstract available


  234. SWENSEN AC, Piehowski PD, Chen J, Chan XY, et al
    Increased inflammation as well as decreased endoplasmic reticulum stress and translation differentiate pancreatic islets from donors with pre-symptomatic stage 1 type 1 diabetes and non-diabetic donors.
    Diabetologia. 2025 Jun 2. doi: 10.1007/s00125-025-06417.
    PubMed     Abstract available


  235. KALE A, Azar M, Cheng V, Robertson H, et al
    Regulating islet stress responses through CD47 activation.
    Diabetologia. 2025;68:1279-1297.
    PubMed     Abstract available


  236. CHEBII VJ, Wade AN, Crowther NJ, Nonterah EA, et al
    Genome-wide association study identifying novel risk variants associated with glycaemic traits in the continental African AWI-Gen cohort.
    Diabetologia. 2025;68:1184-1196.
    PubMed     Abstract available


    May 2025
  237. O'NEILL S, Bidulka P, Lugo-Palacios DG, Carroll O, et al
    Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data.
    Diabetologia. 2025 May 31. doi: 10.1007/s00125-025-06447.
    PubMed     Abstract available


  238. MARTINENGHI S, Merolla A, Grogan P, Bianconi E, et al
    Prevention of diabetic ketoacidosis in relatives screened for islet autoantibodies and followed up in the TrialNet Pathway to Prevention study at a single institution in Italy.
    Diabetologia. 2025 May 29. doi: 10.1007/s00125-025-06461.
    PubMed     Abstract available


  239. HOLT RIG, Tsapas A, Meireles M, Mulder H, et al
    Clinical guidelines and other guidance from the European Association for the Study of Diabetes (EASD).
    Diabetologia. 2025 May 26. doi: 10.1007/s00125-025-06378.
    PubMed    


  240. MEIRELES M, Holt RIG, Tsapas A, Mulder H, et al
    The new era of European Association for the Study of Diabetes (EASD) clinical guidance documents.
    Diabetologia. 2025 May 26. doi: 10.1007/s00125-025-06452.
    PubMed    


  241. KARAGIANNIS T, Advani A, Davies MJ, Del Prato S, et al
    European Association for the Study of Diabetes (EASD) Standard Operating Procedure for the development of guidelines.
    Diabetologia. 2025 May 26. doi: 10.1007/s00125-025-06370.
    PubMed     Abstract available


  242. HENI M, Fruhwald L, Karges W, Naudorf M, et al
    Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register - an IMI-SOPHIA study.
    Diabetologia. 2025 May 22. doi: 10.1007/s00125-025-06448.
    PubMed     Abstract available


  243. MOLLER PM, Kjobsted R, Petersen MH, de Almeida ME, et al
    Effect of acute exercise and exercise training on the ability of insulin to clear branched-chain amino acids from plasma in obesity and type 2 diabetes.
    Diabetologia. 2025 May 22. doi: 10.1007/s00125-025-06454.
    PubMed     Abstract available


  244. GOULDING RP, Charlton BT, Breedveld EA, Huijts JY, et al
    Skeletal muscle mitochondrial health in type 1 diabetes: the role of exercise capacity and lifestyle factors.
    Diabetologia. 2025 May 21. doi: 10.1007/s00125-025-06451.
    PubMed     Abstract available


  245. FERRAT LA, Templeman EL, Steck AK, Parikh HM, et al
    Type 1 diabetes prediction in autoantibody-positive individuals: performance, time and money matter.
    Diabetologia. 2025 May 10. doi: 10.1007/s00125-025-06434.
    PubMed     Abstract available


  246. LINGVAY I, Benamar M, Chen L, Fu A, et al
    Correction: Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial.
    Diabetologia. 2025 May 5. doi: 10.1007/s00125-025-06435.
    PubMed    


  247. LIM CE, Pasternak B, Eliasson B, Ueda P, et al
    Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes.
    Diabetologia. 2025 May 2. doi: 10.1007/s00125-025-06439.
    PubMed     Abstract available


  248. TAYLOR R
    Aetiology of type 2 diabetes: an experimental medicine odyssey.
    Diabetologia. 2025 May 2. doi: 10.1007/s00125-025-06428.
    PubMed     Abstract available


  249. ZHANG Y, Li Y, Liu Y, Willett WC, et al
    Duration and type of statin use and long-term risk of type 2 diabetes among men and women with hypercholesterolaemia: findings from three prospective cohorts.
    Diabetologia. 2025 May 2. doi: 10.1007/s00125-025-06441.
    PubMed     Abstract available


  250. CIANGURA C, Seco A, Saint-Martin C, Ancel PY, et al
    Pregnancy and neonatal outcomes in women with GCK-MODY: an observational study based on standardised insulin modalities.
    Diabetologia. 2025;68:981-992.
    PubMed     Abstract available


    April 2025
  251. SAGAR RC, Yates DM, Pearson SM, Kietsiriroje N, et al
    Insulin resistance in type 1 diabetes is a key modulator of platelet hyperreactivity.
    Diabetologia. 2025 Apr 30. doi: 10.1007/s00125-025-06429.
    PubMed     Abstract available


  252. ADESHARA K, Parente EB, Harjutsalo V, Lehto M, et al
    Relationship between sRAGE and obesity in individuals with type 1 diabetes during a median follow-up of 6.3 years.
    Diabetologia. 2025 Apr 29. doi: 10.1007/s00125-025-06440.
    PubMed     Abstract available


  253. PURVIS GSD, Chiazza F, Chen J, Azevedo-Loiola R, et al
    Retraction Note: Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes.
    Diabetologia. 2025 Apr 29. doi: 10.1007/s00125-025-06418.
    PubMed    


  254. LEWIS CTA, Moreno-Justicia R, Savoure L, Calvo E, et al
    Dysregulated skeletal muscle myosin super-relaxation and energetics in male participants with type 2 diabetes mellitus.
    Diabetologia. 2025 Apr 28. doi: 10.1007/s00125-025-06436.
    PubMed     Abstract available


  255. EEG-OLOFSSON K, Nathanson D, Spelman T, Kyhlstedt M, et al
    Severe hypoglycaemia is associated with increased risk of adverse cardiovascular complications in adults with type 1 diabetes: risk mitigation using intermittently scanned continuous glucose monitoring.
    Diabetologia. 2025 Apr 24. doi: 10.1007/s00125-025-06438.
    PubMed     Abstract available


  256. ZHOU J, Mychaleckyj JC, Onengut-Gumuscu S, Orchard TJ, et al
    DNA methylation and 28 year incidence of two neuropathy phenotypes in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications cohort study.
    Diabetologia. 2025 Apr 23. doi: 10.1007/s00125-025-06427.
    PubMed     Abstract available


  257. BRUCE DG, Davis WA, Chubb SAP, Davis TME, et al
    The relationship between shrunken pore syndrome and all-cause mortality in people with type 2 diabetes and normal renal function: the Fremantle Diabetes Study Phase II.
    Diabetologia. 2025 Apr 21. doi: 10.1007/s00125-025-06430.
    PubMed     Abstract available


  258. BOULTON AJM, Jenkins AJ, Makkar B, Mankovsky B, et al
    Diabetes and natural and man-made disasters: prevention, preparation, response and recovery.
    Diabetologia. 2025 Apr 15. doi: 10.1007/s00125-025-06406.
    PubMed     Abstract available


  259. ZAPARDIEL-GONZALO J, Ziegler AG, Bonifacio E
    The genetic architecture of type 1 diabetes over time: how well can we rely on past data to predict the future?
    Diabetologia. 2025 Apr 12. doi: 10.1007/s00125-025-06422.
    PubMed    


  260. SCHAIN M, Johansson E, Laitinen I, Froden Lowenmark A, et al
    Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-epsilon4.
    Diabetologia. 2025 Apr 11. doi: 10.1007/s00125-025-06405.
    PubMed     Abstract available


  261. BANGSHAAB M, Svart MV, Rittig N, Pedersen MGB, et al
    Metabolic effects of 3-hydroxybutyrate infusion in individuals with type 1 diabetes compared with healthy control participants: a randomised crossover trial showing intact feedback suppression of lipolysis.
    Diabetologia. 2025 Apr 10. doi: 10.1007/s00125-025-06423.
    PubMed     Abstract available


  262. PRASAD RB, Hakaste L, Tuomi T
    Clinical use of polygenic scores in type 2 diabetes: challenges and possibilities.
    Diabetologia. 2025 Apr 5. doi: 10.1007/s00125-025-06419.
    PubMed     Abstract available


  263. VELMURUGAN S, Pandey VK, Verma N, Kotiya D, et al
    Cardiac remodelling, recognition memory deficits and accelerated ageing in a rat model of gestational diabetes.
    Diabetologia. 2025 Apr 5. doi: 10.1007/s00125-025-06421.
    PubMed     Abstract available


  264. RIDDELL MC, Heller S, Carstensen L, Rocha TMP, et al
    The effect of once-weekly insulin icodec vs once-daily basal insulin on physical activity-attributed hypoglycaemia in type 2 diabetes: a post hoc analysis of ONWARDS 1-5.
    Diabetologia. 2025 Apr 5. doi: 10.1007/s00125-025-06414.
    PubMed     Abstract available


    March 2025
  265. KAYA S, Khamees A, Geerling G, Strzalkowski P, et al
    Macular perfusion alterations in people with recent-onset diabetes and novel diabetes subtypes.
    Diabetologia. 2025 Mar 31. doi: 10.1007/s00125-025-06407.
    PubMed     Abstract available


  266. MONTGOMERY MK, Lin S, Yang CH, Prasad K, et al
    HEXA-FC protein therapy increases skeletal muscle glucose uptake and improves glycaemic control in mice with insulin resistance and in a mouse model of type 2 diabetes.
    Diabetologia. 2025 Mar 29. doi: 10.1007/s00125-025-06413.
    PubMed     Abstract available


  267. DELIYANTI D, Suphapimol V, Joglekar A, Jayasimhan A, et al
    Immunotherapy with low-dose IL-2 attenuates vascular injury in mice with diabetic and neovascular retinopathy by restoring the balance between Foxp3(+) Tregs and CD8(+) T cells.
    Diabetologia. 2025 Mar 25. doi: 10.1007/s00125-025-06412.
    PubMed     Abstract available


  268. MORIERI ML, Rigato M, Frison V, D'Ambrosio M, et al
    Early weight loss, diabetes remission and long-term trajectory after diagnosis of type 2 diabetes: a retrospective study.
    Diabetologia. 2025 Mar 22. doi: 10.1007/s00125-025-06402.
    PubMed     Abstract available


  269. BONIFACIO E, Coelho R, Ewald DA, Gemulla G, et al
    The efficacy of islet autoantibody screening with or without genetic pre-screening strategies for the identification of presymptomatic type 1 diabetes.
    Diabetologia. 2025 Mar 19. doi: 10.1007/s00125-025-06408.
    PubMed     Abstract available


  270. LAIHO JE, Oikarinen S, Morfopoulou S, Oikarinen M, et al
    Detection of enterovirus RNA in pancreas and lymphoid tissues of organ donors with type 1 diabetes.
    Diabetologia. 2025 Mar 17. doi: 10.1007/s00125-025-06359.
    PubMed     Abstract available


  271. RODRIGUEZ-CALVO T, Laiho JE, Oikarinen M, Akhbari P, et al
    Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes.
    Diabetologia. 2025 Mar 17. doi: 10.1007/s00125-025-06384.
    PubMed     Abstract available


  272. RICHARDSON SJ, Rodriguez-Calvo T, Laiho JE, Kaddis JS, et al
    Joint analysis of the nPOD-Virus Group data: the association of enterovirus with type 1 diabetes is supported by multiple markers of infection in pancreas tissue.
    Diabetologia. 2025 Mar 17. doi: 10.1007/s00125-025-06401.
    PubMed     Abstract available


  273. LEE H, Fernandes M, Lee J, Merino J, et al
    Exploring the shared genetic landscape of diabetes and cardiovascular disease: findings and future implications.
    Diabetologia. 2025 Mar 15. doi: 10.1007/s00125-025-06403.
    PubMed     Abstract available


  274. YANG Q, Zhu PW, Wen YJ, Zhang R, et al
    MAP4K4 aggravates microvascular anomalies in diabetic retinopathy in a YTHDF2-dependent manner.
    Diabetologia. 2025 Mar 12. doi: 10.1007/s00125-025-06398.
    PubMed     Abstract available


  275. PITT M, Olvera-Barrios A, Anderson J, Bolter L, et al
    A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk.
    Diabetologia. 2025 Mar 12. doi: 10.1007/s00125-025-06379.
    PubMed     Abstract available


  276. ZHANG N, Sun Q, Zhang J, Zhang R, et al
    Intrapancreatic adipocytes and beta cell dedifferentiation in human type 2 diabetes.
    Diabetologia. 2025 Mar 12. doi: 10.1007/s00125-025-06392.
    PubMed     Abstract available


  277. SORENSEN KV, Justesen JM, Angquist L, Bork-Jensen J, et al
    Rare MTNR1B variants causing diminished MT2 signalling associate with elevated HbA(1c) levels but not with type 2 diabetes.
    Diabetologia. 2025 Mar 10. doi: 10.1007/s00125-025-06381.
    PubMed     Abstract available


  278. ZURIAGA MA, Fuster JJ
    Clonal haematopoiesis of indeterminate potential: an emerging risk factor for type 2 diabetes and related complications.
    Diabetologia. 2025 Mar 10. doi: 10.1007/s00125-025-06393.
    PubMed     Abstract available


  279. PLENGVIDHYA N, Suthon S, Nakdontri T, Teerawattanapong N, et al
    Correction: Islet autoantibodies in Thai individuals diagnosed with type 1 diabetes before 30 years of age: a large multicentre nationwide study.
    Diabetologia. 2025 Mar 10. doi: 10.1007/s00125-025-06404.
    PubMed    


  280. TSOI AT, Sng J, Tummanapalli SS, Issar T, et al
    Metformin therapy modifies corneal neuroimmune abnormalities in people with type 2 diabetes.
    Diabetologia. 2025 Mar 7. doi: 10.1007/s00125-025-06399.
    PubMed     Abstract available


  281. YIN W, Zou S, Sha M, Sun L, et al
    Gain of pancreatic beta cell-specific SCD1 improves glucose homeostasis by maintaining functional beta cell mass under metabolic stress.
    Diabetologia. 2025;68:629-645.
    PubMed     Abstract available


  282. REDONDO MJ, Cuthbertson D, Steck AK, Herold KC, et al
    Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes.
    Diabetologia. 2025;68:588-601.
    PubMed     Abstract available


  283. MORALES DD, Ryu J, Wei C, Hadley JT, et al
    Diet-enhanced LRG1 expression promotes insulin hypersecretion and ER stress in pancreatic beta cells.
    Diabetologia. 2025;68:615-628.
    PubMed     Abstract available


  284. WANG Q, Leask MP, Lee K, Jaiswal J, et al
    The population-specific Thr44Met OCT3 coding variant affects metformin pharmacokinetics with subsequent effects on insulin sensitivity in C57Bl/6J mice.
    Diabetologia. 2025;68:537-548.
    PubMed     Abstract available


    February 2025
  285. MOULDER R, Hirvonen MK, Valikangas T, Suomi T, et al
    Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease.
    Diabetologia. 2025 Feb 28. doi: 10.1007/s00125-025-06394.
    PubMed     Abstract available


  286. KOFOD DH, Diederichsen SZ, Bomholt T, Andersen MO, et al
    Cardiac arrhythmia and hypoglycaemia among individuals with and without diabetes receiving haemodialysis (the CADDY study): a Danish multicentre cohort study.
    Diabetologia. 2025 Feb 28. doi: 10.1007/s00125-025-06388.
    PubMed     Abstract available


  287. SIMS EK, Cuthbertson D, Ferrat LA, Bosi E, et al
    IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes.
    Diabetologia. 2025 Feb 28. doi: 10.1007/s00125-025-06382.
    PubMed     Abstract available


  288. DING S, Xu JL, Tong JY, Cheng YY, et al
    Brown adipose tissue alleviates podocyte apoptosis through NRG4 in a male mouse model of diabetic kidney disease.
    Diabetologia. 2025 Feb 27. doi: 10.1007/s00125-025-06385.
    PubMed     Abstract available


  289. VERSCHUEREN VAN REES N, Ashwin P, McMullan C, Krogvold L, et al
    Beyond the loss of beta cells: a quantitative analysis of islet architecture in adults with and without type 1 diabetes.
    Diabetologia. 2025 Feb 26. doi: 10.1007/s00125-025-06376.
    PubMed     Abstract available


  290. CARLSSON PO, Espes D, Sisay S, Davies LC, et al
    Correction: Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial.
    Diabetologia. 2025 Feb 25. doi: 10.1007/s00125-025-06371.
    PubMed    


  291. XIAO Q, Feng Q, Rutter MK, Albalak G, et al
    Associations between the timing of 24 h physical activity and diabetes mellitus: results from a nationally representative sample of the US population.
    Diabetologia. 2025 Feb 21. doi: 10.1007/s00125-025-06368.
    PubMed     Abstract available


  292. PLENGVIDHYA N, Suthon S, Nakdontri T, Teerawattanapong N, et al
    Islet autoantibodies in Thai individuals individuals diagnosed with type 1 diabetes before 30 years of age: a large multicentre nationwide study.
    Diabetologia. 2025 Feb 19. doi: 10.1007/s00125-025-06373.
    PubMed     Abstract available


  293. VENKATARAGHAVAN S, Pankow JS, Boerwinkle E, Fornage M, et al
    Epigenome-wide association study of incident type 2 diabetes in Black and White participants from the Atherosclerosis Risk in Communities Study.
    Diabetologia. 2025 Feb 19. doi: 10.1007/s00125-024-06352.
    PubMed     Abstract available


  294. JONES DL, Kusinski LC, Gillies C, Meek CL, et al
    How should we define subtypes of gestational diabetes mellitus? Reply to Gobl C, Tura A [letter].
    Diabetologia. 2025 Feb 15. doi: 10.1007/s00125-025-06375.
    PubMed    


  295. GOBL C, Tura A
    How should we define subtypes of gestational diabetes mellitus?
    Diabetologia. 2025 Feb 15. doi: 10.1007/s00125-025-06374.
    PubMed    


  296. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
    Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].
    Diabetologia. 2025 Feb 12. doi: 10.1007/s00125-024-06350.
    PubMed    


  297. KORNUM DS, Krogh K, Keller J, Malagelada C, et al
    Diabetic gastroenteropathy: a pan-alimentary complication.
    Diabetologia. 2025 Feb 11. doi: 10.1007/s00125-025-06365.
    PubMed     Abstract available


  298. CALHOUN P, Spanbauer C, Steck AK, Frohnert BI, et al
    Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development.
    Diabetologia. 2025 Feb 11. doi: 10.1007/s00125-025-06362.
    PubMed     Abstract available


  299. DE MEULEMEESTER J, Keymeulen B, De Block C, Van Huffel L, et al
    One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes: a prospective observational cohort study.
    Diabetologia. 2025 Feb 11. doi: 10.1007/s00125-025-06366.
    PubMed     Abstract available


  300. KOWALL B, Rathmann W
    Partnership and marriage and risk of type 2 diabetes: a narrative review.
    Diabetologia. 2025 Feb 7. doi: 10.1007/s00125-025-06360.
    PubMed     Abstract available


  301. LIN YK, Ye W, Hepworth E, Agni A, et al
    Characterising impaired awareness of hypoglycaemia and associated risks through HypoA-Q: findings from a T1D Exchange cohort.
    Diabetologia. 2025;68:433-443.
    PubMed     Abstract available


  302. HANSEN AL, Christiansen CF, Brons C, Engelhard LM, et al
    Birthweight and risk of chronic kidney disease after a type 2 diabetes diagnosis in the DD2 cohort.
    Diabetologia. 2025 Feb 1. doi: 10.1007/s00125-024-06357.
    PubMed     Abstract available


    January 2025
  303. FAN KS, Manoli A, Baumann PM, Shojaee-Moradie F, et al
    Comparison of continuous glucose monitoring with self-monitoring of blood glucose in type 1 diabetes in the changing atmospheric pressures in aviation: a hypobaric flight simulation.
    Diabetologia. 2025 Jan 31. doi: 10.1007/s00125-025-06364.
    PubMed     Abstract available


  304. ZHUANG S, Sun N, Qu J, Chen Q, et al
    High glucose/ChREBP-induced Hif-1alpha transcriptional activation in CD4(+) T cells reduces the risk of diabetic kidney disease by inhibiting the Th1 response.
    Diabetologia. 2025 Jan 30. doi: 10.1007/s00125-024-06354.
    PubMed     Abstract available


  305. FLOYD JL, Prasad R, Dupont MD, Adu-Rutledge Y, et al
    Intestinal neutrophil extracellular traps promote gut barrier damage exacerbating endotoxaemia, systemic inflammation and progression of diabetic retinopathy in type 2 diabetes.
    Diabetologia. 2025 Jan 28. doi: 10.1007/s00125-024-06349.
    PubMed     Abstract available


  306. MUELLER J, Breeze P, Fusco F, Sharp SJ, et al
    Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagn
    Diabetologia. 2025 Jan 23. doi: 10.1007/s00125-024-06355.
    PubMed     Abstract available


  307. COLLINS J, Farnsworth NL
    Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers.
    Diabetologia. 2025 Jan 23. doi: 10.1007/s00125-024-06356.
    PubMed     Abstract available


  308. MENDOZA K, Barquera S, Tobias DK
    Targeting ultra-processed foods for prevention of type 2 diabetes: state of the evidence and future directions.
    Diabetologia. 2025 Jan 18. doi: 10.1007/s00125-025-06358.
    PubMed     Abstract available


  309. LINGVAY I, Benamar M, Chen L, Fu A, et al
    Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial.
    Diabetologia. 2025 Jan 17. doi: 10.1007/s00125-024-06348.
    PubMed     Abstract available


  310. CHEN Z, Qian F, Liu B, Zong G, et al
    Monounsaturated fatty acids from plant or animal sources and risk of type 2 diabetes in three large prospective cohorts of men and women.
    Diabetologia. 2025 Jan 14. doi: 10.1007/s00125-024-06353.
    PubMed     Abstract available


  311. PACHECO LS, Tobias DK, Haslam DE, Drouin-Chartier JP, et al
    Sugar-sweetened or artificially sweetened beverage consumption, physical activity and risk of type 2 diabetes in US adults.
    Diabetologia. 2025 Jan 8. doi: 10.1007/s00125-024-06351.
    PubMed     Abstract available


  312. HIRVELA L, Haukka J, Keski-Rahkonen A, Sipila PN, et al
    Eating disorders among people with and without type 1 diabetes: incidence and treatment in a nationwide population-based cohort.
    Diabetologia. 2025 Jan 4. doi: 10.1007/s00125-024-06346.
    PubMed     Abstract available


  313. CHIMIENTI R, Torchio S, Siracusano G, Zamarian V, et al
    A WFS1 variant disrupting acceptor splice site uncovers the impact of alternative splicing on beta cell apoptosis in a patient with Wolfram syndrome.
    Diabetologia. 2025;68:128-151.
    PubMed     Abstract available


  314. FU Q, Dai H, Shen S, He Y, et al
    Interactions of genes with alcohol consumption affect insulin sensitivity and beta cell function.
    Diabetologia. 2025;68:116-127.
    PubMed     Abstract available


  315. AHN M, Dhawan S, McCown EM, Garcia PA, et al
    Beta cell-specific PAK1 enrichment ameliorates diet-induced glucose intolerance in mice by promoting insulin biogenesis and minimising beta cell apoptosis.
    Diabetologia. 2025;68:152-165.
    PubMed     Abstract available


    December 2024
  316. NADEAU KJ, Arslanian SA, Bacha F, Caprio S, et al
    Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial.
    Diabetologia. 2024 Dec 20. doi: 10.1007/s00125-024-06327.
    PubMed     Abstract available


  317. COLE A, Weight N, Misra S, Grapsa J, et al
    Correction: Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study.
    Diabetologia. 2024 Dec 20. doi: 10.1007/s00125-024-06337.
    PubMed    


  318. SHAPIRO MR, Tallon EM, Brown ME, Posgai AL, et al
    Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes.
    Diabetologia. 2024 Dec 19. doi: 10.1007/s00125-024-06339.
    PubMed     Abstract available


  319. WERNROTH ML, Kennedy B, Fall K, Nguyen D, et al
    Bereavement and type 1 diabetes in childhood: a register-based cohort study in Sweden.
    Diabetologia. 2024 Dec 19. doi: 10.1007/s00125-024-06340.
    PubMed     Abstract available


  320. BITARAFAN V, Anjom-Shoae J, Rezaie P, Fitzgerald PCE, et al
    Dose-related effects of intraduodenal quinine on plasma glucose, glucoregulatory hormones and gastric emptying of a nutrient drink, and energy intake, in men with type 2 diabetes: a double-blind, randomised, crossover study.
    Diabetologia. 2024 Dec 18. doi: 10.1007/s00125-024-06344.
    PubMed     Abstract available


  321. KRISTENSEN FPB, Domazet SL, Nielsen JS, Stidsen JV, et al
    Elevated risk of infection in individuals with hyperinsulinaemic type 2 diabetes: a Danish 12 year cohort study.
    Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06342.
    PubMed     Abstract available


  322. PERKINS BA, Turner LV, Riddell MC
    Correction: Applying technologies to simplify strategies for exercise in type 1 diabetes.
    Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06317.
    PubMed    


  323. SMEIJER JD, de Vries ST, Kohan DE, Hou FF, et al
    Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial.
    Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06326.
    PubMed     Abstract available


  324. DE VRIES ST, Pena MJ, Tye SC, Peters SAE, et al
    Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials.
    Diabetologia. 2024 Dec 10. doi: 10.1007/s00125-024-06325.
    PubMed     Abstract available


  325. MOSER O, Zaharieva DP, Adolfsson P, Battelino T, et al
    The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPA
    Diabetologia. 2024 Dec 10. doi: 10.1007/s00125-024-06308.
    PubMed     Abstract available


  326. BROWN ME, Thirawatananond P, Peters LD, Kern EJ, et al
    Inhibition of CD226 co-stimulation suppresses diabetes development in the NOD mouse by augmenting regulatory T cells and diminishing effector T cell function.
    Diabetologia. 2024 Dec 5. doi: 10.1007/s00125-024-06329.
    PubMed     Abstract available


  327. MACKENBACH JD, Stuber JM, Beulens JWJ
    Evidence on the effectiveness and equity of population-based policies to reduce the burden of type 2 diabetes: a narrative review.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06330.
    PubMed     Abstract available


  328. JONES DL, Kusinski LC, Gillies C, Meek CL, et al
    A critique of measurement of defective insulin secretion and insulin sensitivity as a precision approach to gestational diabetes.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06334.
    PubMed     Abstract available


  329. VIRTANEN JK, Hantunen S, Kallio N, Lamberg-Allardt C, et al
    The effect of vitamin D(3) supplementation on the incidence of type 2 diabetes in healthy older adults not at high risk for diabetes (FIND): a randomised controlled trial.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06336.
    PubMed     Abstract available


  330. CHEN Y, Torta F, Koh HWL, Benke PI, et al
    Metabolomics profiling in multi-ancestral individuals with type 2 diabetes in Singapore identified metabolites associated with renal function decline.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06324.
    PubMed     Abstract available


  331. ZEMSKI BERRY KA, Garfield A, Jambal P, Zarini S, et al
    Oxidised phosphatidylcholine induces sarcolemmal ceramide accumulation and insulin resistance in skeletal muscle.
    Diabetologia. 2024;67:2819-2832.
    PubMed     Abstract available


  332. WAT LW, Svensson KJ
    Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases.
    Diabetologia. 2024;67:2626-2636.
    PubMed     Abstract available


    November 2024
  333. TRICO D, Sacchetta L, Rebelos E, Cimbalo N, et al
    Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications.
    Diabetologia. 2024 Nov 29. doi: 10.1007/s00125-024-06312.
    PubMed     Abstract available


  334. GALDERISI A, Carr ALJ, Martino M, Taylor P, et al
    Correction: Quantifying beta cell function in the preclinical stages of type 1 diabetes.
    Diabetologia. 2024 Nov 27. doi: 10.1007/s00125-024-06335.
    PubMed    


  335. HANICK CJ, Peterson CM, Davis BC, Sabate J, et al
    Correction: A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Nov 25. doi: 10.1007/s00125-024-06332.
    PubMed    


  336. O CK, Fan B, Tsoi STF, Tam CHT, et al
    A polygenic risk score derived from common variants of monogenic diabetes genes is associated with young-onset type 2 diabetes and cardiovascular-kidney complications.
    Diabetologia. 2024 Nov 23. doi: 10.1007/s00125-024-06320.
    PubMed     Abstract available


  337. GALDERISI A, Sims EK, Evans-Molina C, Petrelli A, et al
    Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab.
    Diabetologia. 2024 Nov 19. doi: 10.1007/s00125-024-06323.
    PubMed     Abstract available


  338. LAESSER CI, Piazza C, Schorno N, Nick F, et al
    Simplified meal announcement study (SMASH) using hybrid closed-loop insulin delivery in youth and young adults with type 1 diabetes: a randomised controlled two-centre crossover trial.
    Diabetologia. 2024 Nov 19. doi: 10.1007/s00125-024-06319.
    PubMed     Abstract available


  339. YU G, Tam CHT, Lim CKP, Shi M, et al
    Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes.
    Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06309.
    PubMed     Abstract available


  340. ROONEY MR, Wallace AS, Echouffo Tcheugui JB, Fang M, et al
    Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes.
    Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06315.
    PubMed     Abstract available


  341. PHILLIPS NE, Mareschal J, Biancolin AD, Sinturel F, et al
    The metabolic and circadian signatures of gestational diabetes in the postpartum period characterised using multiple wearable devices.
    Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06318.
    PubMed     Abstract available


  342. WANG E, Patorno E, Khosrow-Khavar F, Crystal S, et al
    Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013-2019.
    Diabetologia. 2024 Nov 8. doi: 10.1007/s00125-024-06321.
    PubMed     Abstract available


  343. AMR RA, Al-Smadi AM, Akasheh RT
    Diabetes knowledge and behaviour: a cross-sectional study of Jordanian adults.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06304.
    PubMed     Abstract available


  344. ELEFTHERIADOU A, Riley D, Zhao SS, Austin P, et al
    Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on diabetic eye complications. Reply to Tsai Y-H, Hemphill NO, Kurth T.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06314.
    PubMed    



  345. Correction: 60(th) EASD Annual Meeting of the European Association for the Study of Diabetes, Madrid, Spain, 9-13 September 2024. 'Average glucose and HbA(1c) display a nonlinear and variable relationship: implications for clinical practice'.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06294.
    PubMed    


  346. LAN NSR, Hiew J, Ferreira I, Ritter JC, et al
    Increased risk of major adverse cardiovascular events in patients with deep and infected diabetes-related foot ulcers.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06316.
    PubMed     Abstract available


  347. GOTTMANN P, Speckmann T, Stadion M, Chawla P, et al
    Transcriptomic heterogeneity of non-beta islet cells is associated with type 2 diabetes development in mouse models.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06301.
    PubMed     Abstract available


  348. RAO C, Cater DT, Roy S, Xu J, et al
    Beta cell extracellular vesicle PD-L1 as a novel regulator of CD8(+) T cell activity and biomarker during the evolution of type 1 diabetes.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06313.
    PubMed     Abstract available


  349. MA RCW, Tam CHT, Hou Y, Lau ESH, et al
    NT-proBNP improves prediction of cardiorenal complications in type 2 diabetes: the Hong Kong Diabetes Biobank.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06299.
    PubMed     Abstract available


  350. GESUITA R, Eckert AJ, Besancon S, Crimmins NA, et al
    Frequency and clinical characteristics of children and young people with type 2 diabetes at diagnosis from five world regions between 2012 and 2021: data from the SWEET Registry.
    Diabetologia. 2024 Nov 6. doi: 10.1007/s00125-024-06283.
    PubMed     Abstract available


  351. MEIER DT, de Paula Souza J, Donath MY
    Targeting the NLRP3 inflammasome-IL-1beta pathway in type 2 diabetes and obesity.
    Diabetologia. 2024 Nov 4. doi: 10.1007/s00125-024-06306.
    PubMed     Abstract available


  352. GARDEN GL, Fan KS, Paterson M, Shojaee-Moradie F, et al
    Effects of atmospheric pressure change during flight on insulin pump delivery and glycaemic control of pilots with insulin-treated diabetes: an in vitro simulation and a retrospective observational real-world study.
    Diabetologia. 2024 Nov 4. doi: 10.1007/s00125-024-06295.
    PubMed     Abstract available


  353. GLINTBORG D, Christensen LL, Andersen MS
    Transgender healthcare: metabolic outcomes and cardiovascular risk.
    Diabetologia. 2024;67:2393-2403.
    PubMed     Abstract available



  354. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.
    Diabetologia. 2024;67:2375-2392.
    PubMed     Abstract available


    October 2024
  355. HOSTRUP PE, Schmidt T, Hellsten SB, Gerwig RH, et al
    Effect of fenofibrate on residual beta cell function in adults and adolescents with newly diagnosed type 1 diabetes: a randomised clinical trial.
    Diabetologia. 2024 Oct 30. doi: 10.1007/s00125-024-06290.
    PubMed     Abstract available


  356. TSAI YH, OjiNjideka Hemphill N, Kurth T
    Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on risk of diabetic eye complications.
    Diabetologia. 2024 Oct 30. doi: 10.1007/s00125-024-06300.
    PubMed    


  357. VOETS PJGM
    A modified total body water deficit formula for use in diabetes care.
    Diabetologia. 2024 Oct 29. doi: 10.1007/s00125-024-06311.
    PubMed    


  358. HANNA SJ, Bonami RH, Corrie B, Westley M, et al
    The Type 1 Diabetes T Cell Receptor and B Cell Receptor Repository in the AIRR Data Commons: a practical guide for access, use and contributions through the Type 1 Diabetes AIRR Consortium.
    Diabetologia. 2024 Oct 29. doi: 10.1007/s00125-024-06298.
    PubMed     Abstract available


  359. SANTOSO C, Wei Y, Ahlqvist E, Tuomi T, et al
    Autoimmune diseases and the risk and prognosis of latent autoimmune diabetes in adults.
    Diabetologia. 2024 Oct 28. doi: 10.1007/s00125-024-06303.
    PubMed     Abstract available


  360. EDSTORP J, Rossides M, Ahlqvist E, Alfredsson L, et al
    Exposure to antibiotics and risk of latent autoimmune diabetes in adults and type 2 diabetes: results from a Swedish case-control study (ESTRID) and the Norwegian HUNT study.
    Diabetologia. 2024 Oct 28. doi: 10.1007/s00125-024-06302.
    PubMed     Abstract available


  361. NATHANSON D, Eeg-Olofsson K, Spelman T, Bulow E, et al
    Intermittently scanned continuous glucose monitoring compared with blood glucose monitoring is associated with lower HbA(1c) and a reduced risk of hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies.
    Diabetologia. 2024 Oct 26. doi: 10.1007/s00125-024-06289.
    PubMed     Abstract available


  362. MALLONE R
    Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody?positive pre?stage 3 type 1 diabetes.
    Diabetologia. 2024 Oct 24. doi: 10.1007/s00125-024-06296.
    PubMed    


  363. CHILUNGA FP, Mkoma GF
    GLP-1 receptor agonists in lean diabetes in racial and ethnic minority groups: closing the treatment gap.
    Diabetologia. 2024 Oct 21. doi: 10.1007/s00125-024-06297.
    PubMed    


  364. APAOLAZA PS, Chen YC, Grewal K, Lurz Y, et al
    Quantitative analysis of islet prohormone convertase 1/3 expression in human pancreas donors with diabetes.
    Diabetologia. 2024 Oct 15. doi: 10.1007/s00125-024-06275.
    PubMed     Abstract available


  365. CERIELLO A, Prattichizzo F, Berra C
    Is glycaemic control still central in the hierarchy of priorities in type 2 diabetes management? The way forward is to combine glucose control and the prevention of cardiorenal complications.
    Diabetologia. 2024 Oct 4. doi: 10.1007/s00125-024-06284.
    PubMed    


  366. COLE A, Weight N, Mishra S, Grapsa J, et al
    Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study.
    Diabetologia. 2024 Oct 3. doi: 10.1007/s00125-024-06281.
    PubMed     Abstract available


  367. ZHAO LP, Papadopoulos GK, Skyler JS, Pugliese A, et al
    Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers.
    Diabetologia. 2024 Oct 1. doi: 10.1007/s00125-024-06274.
    PubMed     Abstract available


  368. OKURA T, Ito Y, Anno M, Endo S, et al
    Postprandial fatty acid-binding protein 4 is associated with muscle insulin resistance.
    Diabetologia. 2024;67:2304-2315.
    PubMed     Abstract available


  369. YAMAGUCHI M, Nakao S, Arima M, Little K, et al
    Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation.
    Diabetologia. 2024;67:2329-2345.
    PubMed     Abstract available


  370. WU Y, Yang M, Wu SB, Luo PQ, et al
    Zinc finger BED-type containing 3 promotes hepatic steatosis by interacting with polypyrimidine tract-binding protein 1.
    Diabetologia. 2024;67:2346-2366.
    PubMed     Abstract available


  371. MELLOR J, Kuznetsov D, Heller S, Gall MA, et al
    Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
    Diabetologia. 2024;67:2210-2224.
    PubMed     Abstract available


  372. GRENKO CM, Taylor HJ, Bonnycastle LL, Xue D, et al
    Single-cell transcriptomic profiling of human pancreatic islets reveals genes responsive to glucose exposure over 24 h.
    Diabetologia. 2024;67:2246-2259.
    PubMed     Abstract available


    September 2024
  373. LIU S, Zhu J, Zhong H, Wu C, et al
    Identification of proteins associated with type 2 diabetes risk in diverse racial and ethnic populations.
    Diabetologia. 2024 Sep 30. doi: 10.1007/s00125-024-06277.
    PubMed     Abstract available


  374. SHARMA S, Dong Q, Haid M, Adam J, et al
    Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study.
    Diabetologia. 2024 Sep 30. doi: 10.1007/s00125-024-06282.
    PubMed     Abstract available


  375. HOLMAN N, Yelland AC, Young B, Valabhji J, et al
    Mortality rates in people presenting with a new diabetes-related foot ulcer: a cohort study with implications for management.
    Diabetologia. 2024 Sep 27. doi: 10.1007/s00125-024-06262.
    PubMed     Abstract available


  376. HANICK CJ, Peterson CM, Davis BC, Sabate J, et al
    A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Sep 21. doi: 10.1007/s00125-024-06272.
    PubMed     Abstract available


  377. ELBARBARY NS, Ismail EA, El-Hamamsy MH, Ibrahim MZ, et al
    The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial.
    Diabetologia. 2024 Sep 14. doi: 10.1007/s00125-024-06265.
    PubMed     Abstract available


  378. TSATSARIS G, Rajamand Ekberg N, Fall T, Catrina SB, et al
    Risk factors for Charcot foot development in individuals with diabetes mellitus.
    Diabetologia. 2024 Sep 13. doi: 10.1007/s00125-024-06271.
    PubMed     Abstract available


  379. HEIKKILA TE, Kaiser EK, Lin J, Gill D, et al
    Genetic evidence for efficacy of targeting IL-2, IL-6 and TYK2 signalling in the prevention of type 1 diabetes: a Mendelian randomisation study.
    Diabetologia. 2024 Sep 13. doi: 10.1007/s00125-024-06267.
    PubMed     Abstract available


  380. LAVENS A, De Block C, Oriot P, Crenier L, et al
    Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study.
    Diabetologia. 2024 Sep 13. doi: 10.1007/s00125-024-06273.
    PubMed     Abstract available



  381. 60(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Madrid, Spain, 9 - 13 September 2024.
    Diabetologia. 2024 Sep 12. doi: 10.1007/s00125-024-06226.
    PubMed    


  382. GALINDO RJ, Soliman D, Chernavvsky D, Rhee CM, et al
    Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease.
    Diabetologia. 2024 Sep 10. doi: 10.1007/s00125-024-06278.
    PubMed    


  383. LENZEN S
    Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes.
    Diabetologia. 2024 Sep 7. doi: 10.1007/s00125-024-06264.
    PubMed    


  384. SORIA-CONTRERAS DC, Wang S, Liu J, Lawn RB, et al
    Lifetime history of gestational diabetes and cognitive function in parous women in midlife.
    Diabetologia. 2024 Sep 6. doi: 10.1007/s00125-024-06270.
    PubMed     Abstract available


  385. WACHOWSKI NA, Pippin JA, Boehm K, Lu S, et al
    Implicating type 2 diabetes effector genes in relevant metabolic cellular models using promoter-focused Capture-C.
    Diabetologia. 2024 Sep 6. doi: 10.1007/s00125-024-06261.
    PubMed     Abstract available


  386. EIZIRIK DL, Zimath PL, Yi X, Roca Rivada A, et al
    Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes. Reply to Lenzen S [letter].
    Diabetologia. 2024 Sep 5. doi: 10.1007/s00125-024-06269.
    PubMed    


  387. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
    Correction to: Consensus guidance for monitoring individuals with islet autoantibody?positive pre?stage 3 type 1 diabetes.
    Diabetologia. 2024 Sep 4. doi: 10.1007/s00125-024-06266.
    PubMed    


  388. THOMSON RL, Brown JD, Oakey H, Palmer K, et al
    Dietary patterns during pregnancy and maternal and birth outcomes in women with type 1 diabetes: the Environmental Determinants of Islet Autoimmunity (ENDIA) study.
    Diabetologia. 2024 Sep 2. doi: 10.1007/s00125-024-06259.
    PubMed     Abstract available


  389. ESSER N, Hogan MF, Templin AT, Akter R, et al
    The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity.
    Diabetologia. 2024;67:1897-1911.
    PubMed     Abstract available


  390. LITHOVIUS V, Lahdenpohja S, Ibrahim H, Saarimaki-Vire J, et al
    Non-invasive quantification of stem cell-derived islet graft size and composition.
    Diabetologia. 2024;67:1912-1929.
    PubMed     Abstract available


  391. WREVEN E, Ruiz de Adana MS, Hardiville S, Gmyr V, et al
    Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.
    Diabetologia. 2024;67:1877-1896.
    PubMed     Abstract available


  392. MAKINEN S, Sree S, Ala-Nisula T, Kultalahti H, et al
    Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men.
    Diabetologia. 2024;67:1943-1954.
    PubMed     Abstract available


    August 2024
  393. DUNNE F, Newman C, Alvarez-Iglesias A, O'Shea P, et al
    Metformin and small for gestational age babies: findings of a randomised placebo-controlled clinical trial of metformin in gestational diabetes (EMERGE).
    Diabetologia. 2024 Aug 31. doi: 10.1007/s00125-024-06252.
    PubMed     Abstract available


  394. MALLIK R, Kar P, Mulder H, Krook A, et al
    The future is here: an overview of technology in diabetes.
    Diabetologia. 2024 Aug 30. doi: 10.1007/s00125-024-06235.
    PubMed    


  395. SCIBILIA R, Breslin-Brooker N, Bright C, Dzikiti T, et al
    Global experiences and personal narratives on diabetes technology and access.
    Diabetologia. 2024 Aug 30. doi: 10.1007/s00125-024-06230.
    PubMed    


  396. LIN DS, Lee JK, Huang KC, Lin TT, et al
    Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease.
    Diabetologia. 2024 Aug 29. doi: 10.1007/s00125-024-06257.
    PubMed     Abstract available


  397. FADINI GP, Longato E, Morieri ML, Bonora E, et al
    Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care.
    Diabetologia. 2024 Aug 23. doi: 10.1007/s00125-024-06251.
    PubMed     Abstract available


  398. TANABE H, Sato M, Miyake A, Shimajiri Y, et al
    Machine learning-based reproducible prediction of type 2 diabetes subtypes.
    Diabetologia. 2024 Aug 21. doi: 10.1007/s00125-024-06248.
    PubMed     Abstract available


  399. KHUNTI K, Zaccardi F, Amod A, Aroda VR, et al
    Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management.
    Diabetologia. 2024 Aug 19. doi: 10.1007/s00125-024-06254.
    PubMed     Abstract available


  400. LEHNER CT, Schauberger G, Klug SJ
    Reduced type 2 diabetes incidence reflecting end of post?World War II calorie restrictions in Germany. Reply to Nilsson PM, Vaag A [letter].
    Diabetologia. 2024 Aug 17. doi: 10.1007/s00125-024-06255.
    PubMed    


  401. PERKINS BA, Turner LV, Riddell MC
    Applying technologies to simplify strategies for exercise in type 1 diabetes.
    Diabetologia. 2024 Aug 15. doi: 10.1007/s00125-024-06229.
    PubMed     Abstract available


  402. NILSSON PM, Vaag A
    Reduced type 2 diabetes incidence reflecting end of post-World War II calorie restrictions in Germany.
    Diabetologia. 2024 Aug 15. doi: 10.1007/s00125-024-06195.
    PubMed    


  403. ADEBEKUN J, Nadig A, Saarah P, Asgari S, et al
    Genetic relations between type 1 diabetes, coronary artery disease and leukocyte counts.
    Diabetologia. 2024 Aug 14. doi: 10.1007/s00125-024-06247.
    PubMed     Abstract available


  404. SMITH K, Taylor GS, Peeters W, Walker M, et al
    Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes.
    Diabetologia. 2024 Aug 13. doi: 10.1007/s00125-024-06249.
    PubMed     Abstract available


  405. MALTESE G, McAuley SA, Trawley S, Sinclair AJ, et al
    Ageing well with diabetes: the role of technology.
    Diabetologia. 2024 Aug 13. doi: 10.1007/s00125-024-06240.
    PubMed     Abstract available


  406. ELEFTHERIADOU A, Spallone V, Tahrani AA, Alam U, et al
    Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management.
    Diabetologia. 2024 Aug 9. doi: 10.1007/s00125-024-06242.
    PubMed     Abstract available


  407. GALINDO RJ, Soliman D, Chernasvvky D, Rhee CM, et al
    Diabetes technology in people with diabetes and advanced chronic kidney disease.
    Diabetologia. 2024 Aug 8. doi: 10.1007/s00125-024-06244.
    PubMed     Abstract available


  408. YOU L, Ferrat LA, Oram RA, Parikh HM, et al
    Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06246.
    PubMed     Abstract available


  409. HAUKKA JK, Antikainen AA, Valo E, Syreeni A, et al
    Whole-exome and whole-genome sequencing of 1064 individuals with type 1 diabetes reveals novel genes for diabetic kidney disease.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06241.
    PubMed     Abstract available


  410. HURTADO I, Robles C, Peiro S, Garcia-Sempere A, et al
    Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06243.
    PubMed     Abstract available


  411. RASHID R, Chaudhry D, Evison F, Sharif A, et al
    Mortality risk for kidney transplant candidates with diabetes: a population cohort study.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06245.
    PubMed     Abstract available



  412. Up Front.
    Diabetologia. 2024;67:1453-1454.
    PubMed    


  413. VISA M, Berggren PO
    Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca(2+) dynamics in prediabetic beta cells.
    Diabetologia. 2024;67:1663-1682.
    PubMed     Abstract available


  414. MELLOR J, Kuznetsov D, Heller S, Gall MA, et al
    Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
    Diabetologia. 2024;67:1588-1601.
    PubMed     Abstract available


  415. WINTHER-SORENSEN M, Garcia SL, Bartholdy A, Ottenheijm ME, et al
    Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study.
    Diabetologia. 2024;67:1602-1615.
    PubMed     Abstract available


    July 2024
  416. MASALIN S, Klavus A, Rono K, Koistinen HA, et al
    Analysis of early-pregnancy metabolome in early- and late-onset gestational diabetes reveals distinct associations with maternal overweight.
    Diabetologia. 2024 Jul 31. doi: 10.1007/s00125-024-06237.
    PubMed     Abstract available


  417. SOHOLM U, Broadley M, Zaremba N, Divilly P, et al
    The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06233.
    PubMed     Abstract available


  418. EHRMANN D, Hermanns N, Schmitt A, Klinker L, et al
    Perceived glucose levels matter more than CGM-based data in predicting diabetes distress in type 1 or type 2 diabetes: a precision mental health approach using n-of-1 analyses.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06239.
    PubMed     Abstract available


  419. VERNSTROM L, Gullaksen S, Sorensen SS, Ringgaard S, et al
    Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06228.
    PubMed     Abstract available


  420. LUNDGAARD AT, Westergaard D, Roder T, Burgdorf KS, et al
    Longitudinal metabolite and protein trajectories prior to diabetes mellitus diagnosis in Danish blood donors: a nested case-control study.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06231.
    PubMed     Abstract available


  421. MOLVEAU J, Myette-Cote E, Tagougui S, Taleb N, et al
    Assessing the influence of insulin type (ultra-rapid vs rapid insulin) and exercise timing on postprandial exercise-induced hypoglycaemia risk in individuals with type 1 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Jul 29. doi: 10.1007/s00125-024-06234.
    PubMed     Abstract available


  422. KONDO A, McGrady M, Nallapothula D, Ali H, et al
    Spatial proteomics of human diabetic kidney disease, from health to class III.
    Diabetologia. 2024 Jul 22. doi: 10.1007/s00125-024-06210.
    PubMed     Abstract available


  423. DONOVAN LE, Bell RC, Feig DS, Lemieux P, et al
    Glycaemic patterns during breastfeeding with postpartum use of closed-loop insulin delivery in women with type 1 diabetes.
    Diabetologia. 2024 Jul 19. doi: 10.1007/s00125-024-06227.
    PubMed     Abstract available


  424. DU S, Sullivan VK, Fang M, Appel LJ, et al
    Ultra-processed food consumption and risk of diabetes: results from a population-based prospective cohort.
    Diabetologia. 2024 Jul 13. doi: 10.1007/s00125-024-06221.
    PubMed     Abstract available


  425. SCULLY KJ, Marks BE, Putman MS
    Advances in diabetes technology to improve the lives of people with cystic fibrosis.
    Diabetologia. 2024 Jul 12. doi: 10.1007/s00125-024-06223.
    PubMed     Abstract available


  426. SCHOELWER MJ, DeBoer MD, Breton MD
    Use of diabetes technology in children.
    Diabetologia. 2024 Jul 12. doi: 10.1007/s00125-024-06218.
    PubMed     Abstract available


  427. WANG W, Bain SC, Bian F, Chen R, et al
    Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06142.
    PubMed     Abstract available


  428. JI L, Agesen RM, Bain SC, Fu F, et al
    Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06133.
    PubMed     Abstract available


  429. LUNA-MARCO C, Devos D, Cacace J, Fernandez-Reyes M, et al
    Molecular circadian clock disruption in the leukocytes of individuals with type 2 diabetes and overweight, and its relationship with leukocyte-endothelial interactions.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06219.
    PubMed     Abstract available


  430. BROZZI F, Jacovetti C, Cosentino C, Menoud V, et al
    tRNA-derived fragments in T lymphocyte-beta cell crosstalk and in type 1 diabetes pathogenesis in NOD mice.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06207.
    PubMed     Abstract available


  431. DE WIT DF, Fuhri Snethlage CM, Rampanelli E, Maasen K, et al
    Higher fibre and lower carbohydrate intake are associated with favourable CGM metrics in a cross-sectional cohort of 470 individuals with type 1 diabetes.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06213.
    PubMed     Abstract available


  432. MCLEAN A, Maple-Brown L, Murphy HR
    Technology advances in diabetes pregnancy: right technology, right person, right time.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06216.
    PubMed     Abstract available


  433. DONNELLY LA, McCrimmon RJ, Pearson ER
    Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world population.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06217.
    PubMed     Abstract available


  434. THABIT H, Schofield J
    Technology in the management of diabetes in hospitalised adults.
    Diabetologia. 2024 Jul 2. doi: 10.1007/s00125-024-06206.
    PubMed     Abstract available



  435. Up Front.
    Diabetologia. 2024;67:1163-1164.
    PubMed    


  436. GYLFE E, Tengholm A
    Bo Hellman, 19 June 1930-4 December 2023.
    Diabetologia. 2024;67:1165-1167.
    PubMed    


  437. BRAKENRIDGE CJ, Koster A, de Galan BE, Carver A, et al
    Associations of 24 h time-use compositions of sitting, standing, physical activity and sleeping with optimal cardiometabolic risk and glycaemic control: The Maastricht Study.
    Diabetologia. 2024;67:1356-1367.
    PubMed     Abstract available


  438. HTOO PT, Tesfaye H, Schneeweiss S, Wexler DJ, et al
    Effectiveness and safety of empagliflozin: final results from the EMPRISE study.
    Diabetologia. 2024;67:1328-1342.
    PubMed     Abstract available


    June 2024
  439. LIARAKOS AL, Lim JZM, Leelarathna L, Wilmot EG, et al
    The use of technology in type 2 diabetes and prediabetes: a narrative review.
    Diabetologia. 2024 Jun 29. doi: 10.1007/s00125-024-06203.
    PubMed     Abstract available


  440. HASLAM DE, Liang L, Guo K, Martinez-Lozano M, et al
    Correction: Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
    Diabetologia. 2024 Jun 28. doi: 10.1007/s00125-024-06199.
    PubMed    


  441. XIAO Q, Full KM, Rutter MK, Lipworth L, et al
    Long-term trajectories of sleep duration are associated with incident diabetes in middle-to-older-aged Black and White Americans.
    Diabetologia. 2024 Jun 27. doi: 10.1007/s00125-024-06202.
    PubMed     Abstract available


  442. KENNEDY B, Wernroth ML, Batra G, Hammar U, et al
    Major cardiovascular events and death in parents of children with type 1 diabetes: a register-based matched cohort study in Sweden.
    Diabetologia. 2024 Jun 26. doi: 10.1007/s00125-024-06200.
    PubMed     Abstract available


  443. FUHRI SNETHLAGE CM, Balvers M, Ferwerda B, Rampanelli E, et al
    Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study.
    Diabetologia. 2024 Jun 26. doi: 10.1007/s00125-024-06204.
    PubMed     Abstract available


  444. BYNDLOSS M, Devkota S, Duca F, Niess JH, et al
    The gut microbiota and diabetes: research, translation, and clinical applications - 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06198.
    PubMed     Abstract available


  445. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
    Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06205.
    PubMed     Abstract available


  446. D'ALESSIO DA, Kahn SE, Mulder H
    The gut microbiota and diabetes: clarity on an emerging topic and introduction to a new partnership and journal feature.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06208.
    PubMed    


  447. UMPIERREZ GE, Davis GM, ElSayed NA, Fadini GP, et al
    Hyperglycaemic crises in adults with diabetes: a consensus report.
    Diabetologia. 2024 Jun 22. doi: 10.1007/s00125-024-06183.
    PubMed     Abstract available


  448. MUTHUKUMAR A, Badawy L, Mangelis A, Vas P, et al
    HbA(1c) variability is independently associated with progression of diabetic kidney disease in an urban multi-ethnic cohort of people with type 1 diabetes.
    Diabetologia. 2024 Jun 20. doi: 10.1007/s00125-024-06197.
    PubMed     Abstract available


  449. GAO L, Ramirez FJ, Cabrera JTO, Varghese MV, et al
    eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes.
    Diabetologia. 2024 Jun 19. doi: 10.1007/s00125-024-06201.
    PubMed     Abstract available


  450. KOBAYASHI Y, Long J, Johannsen NM, Talamoa R, et al
    Is strength training more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes? Reply to Pontes?Silva A, Santos?de?Araujo AD, Teixeira BC et al [letter].
    Diabetologia. 2024 Jun 18. doi: 10.1007/s00125-024-06181.
    PubMed    


  451. WU M, Yoon CY, Park J, Kim G, et al
    The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease.
    Diabetologia. 2024 Jun 15. doi: 10.1007/s00125-024-06191.
    PubMed     Abstract available


  452. MCNEILLY AD, Gallagher JR, Evans ML, de Galan BE, et al
    Correction: Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.
    Diabetologia. 2024 Jun 12. doi: 10.1007/s00125-024-06188.
    PubMed    


  453. GUDEMANN LM, Young KG, Thomas NJM, Hopkins R, et al
    Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach.
    Diabetologia. 2024 Jun 5. doi: 10.1007/s00125-024-06190.
    PubMed     Abstract available


  454. VATANEN T, de Beaufort C, Marcovecchio ML, Overbergh L, et al
    Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study.
    Diabetologia. 2024 Jun 4. doi: 10.1007/s00125-024-06192.
    PubMed     Abstract available


    May 2024
  455. ZHANG J, Zhang R, Liu C, Ge X, et al
    Missense mutation of ISL1 (E283D) is associated with the development of type 2 diabetes.
    Diabetologia. 2024 May 31. doi: 10.1007/s00125-024-06186.
    PubMed     Abstract available


  456. SINGH T, Weiss A, Vehik K, Krischer J, et al
    Caesarean section and risk of type 1 diabetes.
    Diabetologia. 2024 May 31. doi: 10.1007/s00125-024-06176.
    PubMed     Abstract available


  457. JEVON D, Cottle L, Hallahan N, Harwood R, et al
    Capillary contact points determine beta cell polarity, control secretion and are disrupted in the db/db mouse model of diabetes.
    Diabetologia. 2024 May 30. doi: 10.1007/s00125-024-06180.
    PubMed     Abstract available


  458. GROEGLER J, Callebaut A, James EA, Delong T, et al
    The insulin secretory granule is a hotspot for autoantigen formation in type 1 diabetes.
    Diabetologia. 2024 May 29. doi: 10.1007/s00125-024-06164.
    PubMed     Abstract available


  459. SALVATORI B, Wegener S, Kotzaeridi G, Herding A, et al
    Identification and validation of gestational diabetes subgroups by data-driven cluster analysis.
    Diabetologia. 2024 May 27. doi: 10.1007/s00125-024-06184.
    PubMed     Abstract available


  460. DE MEULEMEESTER J, Charleer S, Visser MM, De Block C, et al
    The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.
    Diabetologia. 2024 May 24. doi: 10.1007/s00125-024-06171.
    PubMed     Abstract available


  461. FAGHERAZZI G, Aguayo GA, Zhang L, Hanaire H, et al
    Heterogeneity of glycaemic phenotypes in type 1 diabetes.
    Diabetologia. 2024 May 23. doi: 10.1007/s00125-024-06179.
    PubMed     Abstract available


  462. JUMPERTZ VON SCHWARTZENBERG R, Vazquez Arreola E, Sandforth A, Hanson RL, et al
    Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: time to improve diabetes prevention.
    Diabetologia. 2024 May 23. doi: 10.1007/s00125-024-06178.
    PubMed    


  463. HANSEN AL, Brons C, Engelhard LM, Andersen MK, et al
    Low birthweight in patients with type 2 diabetes is associated with elevated risk of cardiovascular events and mortality.
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06170.
    PubMed     Abstract available


  464. CARLTON J, Powell PA, Broadley M, de Galan BE, et al
    Development of a new health-related quality of life measure for people with diabetes who experience hypoglycaemia: the Hypo-RESOLVE QoL.
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06182.
    PubMed     Abstract available


  465. PONTES-SILVA A, Santos-de-Araujo AD, Teixeira BC, Carteri RB, et al
    Is strength training more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes?
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06121.
    PubMed    


  466. HASLAM DE, Liang L, Guo K, Martinez-Lozano M, et al
    Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
    Diabetologia. 2024 May 21. doi: 10.1007/s00125-024-06169.
    PubMed     Abstract available


  467. YUAN S, Leffler D, Lebwohl B, Green PHR, et al
    Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study.
    Diabetologia. 2024 May 21. doi: 10.1007/s00125-024-06175.
    PubMed     Abstract available


  468. DEL PRATO S, Torbeyns B, Mathieu C
    2024: The year to take European action on diabetes to the next level.
    Diabetologia. 2024 May 18. doi: 10.1007/s00125-024-06166.
    PubMed    


  469. SHEU A, White CP, Center JR
    Bone metabolism in diabetes: a clinician's guide to understanding the bone-glucose interplay.
    Diabetologia. 2024 May 18. doi: 10.1007/s00125-024-06172.
    PubMed     Abstract available


  470. IBRAHIM H, Balboa D, Saarimaki-Vire J, Montaser H, et al
    RFX6 haploinsufficiency predisposes to diabetes through impaired beta cell function.
    Diabetologia. 2024 May 14. doi: 10.1007/s00125-024-06163.
    PubMed     Abstract available


  471. BOUGHTON CK, Hovorka R
    The role of automated insulin delivery technology in diabetes.
    Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06165.
    PubMed     Abstract available


  472. CORPELEIJN WE, de Waal WJ, Schipper HS, Wiegman A, et al
    Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Reply to Sanchez?Hernandez and Wagner [letter].
    Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06174.
    PubMed    


  473. GULLAKSEN S, Vernstrom L, Sorensen SS, Ringgaard S, et al
    Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
    Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06167.
    PubMed    


  474. VAN DER SCHUEREN B, Vrijlandt P, Thomson A, Janssen H, et al
    New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus.
    Diabetologia. 2024 May 4. doi: 10.1007/s00125-024-06162.
    PubMed    


  475. RAUSCHER FG, Elze T, Francke M, Martinez-Perez ME, et al
    Glucose tolerance and insulin resistance/sensitivity associate with retinal layer characteristics: the LIFE-Adult-Study.
    Diabetologia. 2024;67:928-939.
    PubMed     Abstract available


  476. RUISSEN MM, Steyerberg EW, Huisman SD, de Graaf AA, et al
    Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschenes SS [letter].
    Diabetologia. 2024;67:956-957.
    PubMed    


  477. POUWER F, Deschenes S
    Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention.
    Diabetologia. 2024;67:954-955.
    PubMed    


  478. IDEVALL-HAGREN O, Incedal Nilsson C, Sanchez G
    Keeping pace: the primary cilium as the conducting baton of the islet.
    Diabetologia. 2024;67:773-782.
    PubMed     Abstract available


    April 2024
  479. KOBAYASHI Y, Long J, Dan S, Johannsen NM, et al
    Correction to: Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Apr 30. doi: 10.1007/s00125-024-06135.
    PubMed    


  480. TREVISAN R, Conti M, Ciardullo S
    Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes.
    Diabetologia. 2024 Apr 29. doi: 10.1007/s00125-024-06158.
    PubMed     Abstract available


  481. CHEN J, Feng Q, Qiao Y, Pan S, et al
    ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes.
    Diabetologia. 2024 Apr 27. doi: 10.1007/s00125-024-06156.
    PubMed     Abstract available


  482. STERNER ISAKSSON S, Imberg H, Hirsch IB, Schwarcz E, et al
    Discordance between mean glucose and time in range in relation to HbA(1c) in individuals with type 1 diabetes: results from the GOLD and SILVER trials.
    Diabetologia. 2024 Apr 26. doi: 10.1007/s00125-024-06151.
    PubMed     Abstract available


  483. TAYLOR GS, Smith K, Scragg J, McDonald TJ, et al
    The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes.
    Diabetologia. 2024 Apr 25. doi: 10.1007/s00125-024-06153.
    PubMed     Abstract available


  484. DENICOLO S, Reinstadler V, Keller F, Thoni S, et al
    Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus.
    Diabetologia. 2024 Apr 22. doi: 10.1007/s00125-024-06149.
    PubMed     Abstract available


  485. KIM JY, Jin SM, Sim KH, Kim BY, et al
    Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial.
    Diabetologia. 2024 Apr 19. doi: 10.1007/s00125-024-06152.
    PubMed     Abstract available


  486. KIM JY, Jin SM, Kang ES, Kwak SH, et al
    Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial.
    Diabetologia. 2024 Apr 18. doi: 10.1007/s00125-024-06155.
    PubMed     Abstract available


  487. LI X, Donnelly LA, Slieker RC, Beulens JWJ, et al
    Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes.
    Diabetologia. 2024 Apr 16. doi: 10.1007/s00125-024-06147.
    PubMed     Abstract available


  488. SACCO S, Foschi M, Ornello R, De Santis F, et al
    Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.
    Diabetologia. 2024 Apr 16. doi: 10.1007/s00125-024-06146.
    PubMed     Abstract available


  489. KARAGIANNIS T, Malandris K, Avgerinos I, Stamati A, et al
    Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
    Diabetologia. 2024 Apr 13. doi: 10.1007/s00125-024-06144.
    PubMed     Abstract available


  490. METSALA J, Risnes K, Persson M, Veijola R, et al
    Gestational age at birth and type 1 diabetes in childhood and young adulthood: a nationwide register study in Finland, Norway and Sweden.
    Diabetologia. 2024 Apr 13. doi: 10.1007/s00125-024-06139.
    PubMed     Abstract available


  491. VALABHJI J, Holman N, Collins N, Young RJ, et al
    Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementation pilot in England.
    Diabetologia. 2024 Apr 8. doi: 10.1007/s00125-024-06134.
    PubMed     Abstract available


  492. ELEFTHERIADOU A, Riley D, Zhao SS, Austin P, et al
    Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.
    Diabetologia. 2024 Apr 8. doi: 10.1007/s00125-024-06132.
    PubMed     Abstract available


  493. SIERRA-SILVESTRE E, Andrade RJ, Colorado LH, Edwards K, et al
    Correction to: Occurrence of corneal sub-epithelial microneuromas and axonal swelling in people with diabetes with and without (painful) diabetic neuropathy.
    Diabetologia. 2024 Apr 5. doi: 10.1007/s00125-024-06138.
    PubMed    


  494. LIU B, Xie D, Huang X, Jin S, et al
    Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1alpha.
    Diabetologia. 2024;67:724-737.
    PubMed     Abstract available


  495. XIE C, Iroga P, Bound MJ, Grivell J, et al
    Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study.
    Diabetologia. 2024 Apr 1. doi: 10.1007/s00125-024-06131.
    PubMed     Abstract available


    March 2024
  496. KORNUM DS, Bertoli D, Kufaishi H, Wegeberg AM, et al
    Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial.
    Diabetologia. 2024 Mar 28. doi: 10.1007/s00125-024-06129.
    PubMed     Abstract available


  497. VAN DEN BURG EL, Schoonakker MP, van Peet PG, van den Akker-van Marle EM, et al
    Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial.
    Diabetologia. 2024 Mar 28. doi: 10.1007/s00125-024-06137.
    PubMed     Abstract available


  498. MARCOVECCHIO ML, Hendriks AEJ, Delfin C, Battelino T, et al
    The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults.
    Diabetologia. 2024 Mar 22. doi: 10.1007/s00125-024-06124.
    PubMed     Abstract available


  499. TURNER LV, Marak MC, Gal RL, Calhoun P, et al
    Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort.
    Diabetologia. 2024 Mar 19. doi: 10.1007/s00125-024-06127.
    PubMed     Abstract available


  500. LUND-BLIX NA, Bjerregaard AA, Tapia G, Stordal K, et al
    No association between long-chain n-3 fatty acid intake during pregnancy and risk of type 1 diabetes in offspring in two large Scandinavian pregnancy cohorts.
    Diabetologia. 2024 Mar 19. doi: 10.1007/s00125-024-06125.
    PubMed     Abstract available


  501. GUSTAFSON D, DiStefano PV, Wang XF, Wu R, et al
    Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes.
    Diabetologia. 2024 Mar 15. doi: 10.1007/s00125-024-06120.
    PubMed     Abstract available


  502. MONTEYNE AJ, Falkenhain K, Whelehan G, Neudorf H, et al
    A ketone monoester drink reduces postprandial blood glucose concentrations in adults with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Mar 14. doi: 10.1007/s00125-024-06122.
    PubMed     Abstract available


  503. SHE R, Suvitaival T, Andersen HU, Hommel E, et al
    Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals.
    Diabetologia. 2024 Mar 1. doi: 10.1007/s00125-024-06116.
    PubMed     Abstract available


    February 2024
  504. SU M, Hou Y, Cai S, Li W, et al
    Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06109.
    PubMed     Abstract available


  505. JIN Q, Lau ESH, Luk AO, Tam CHT, et al
    Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06108.
    PubMed     Abstract available


  506. REUTRAKUL S, Park JC, McAnany JJ, Chau FY, et al
    Dysregulated 24 h melatonin secretion associated with intrinsically photosensitive retinal ganglion cell function in diabetic retinopathy: a cross-sectional study.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06118.
    PubMed     Abstract available


  507. TER BRAAKE JG, Fleetwood KJ, Vos RC, Blackbourn L, et al
    Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06111.
    PubMed     Abstract available


  508. COOMANS DE BRACHENE A, Alvelos MI, Szymczak F, Zimath PL, et al
    Interferons are key cytokines acting on pancreatic islets in type 1 diabetes.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06106.
    PubMed     Abstract available


  509. LEHNER CT, Eberl M, Donnachie E, Tanaka LF, et al
    Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06113.
    PubMed     Abstract available


  510. SANCHEZ-HERNANDEZ RM, Wagner AM
    Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia?
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06115.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum